Curriculum Vitae

DATIN PROF. DR. ZAHURIN BINTI MOHAMED

Honorary Professor
  • Department of Pharmacology
    Faculty of Medicine
  • zahurin
  • +60379675725

BIOGRAPHY

I obtained my BSc and PhD in Pharmacology from the University of Dundee (UK), joined the University of Malaya as a tutor in 1979, and was promoted to Professor of Pharmacology in 2000. I was the Head of the Department of Pharmacology for over 18 years from 1994, which ended in August 2014, following my appointment into the university's Board of Directors (BOD). My appointment as member of BOD ended in Dec 2015. My main research currently is in pharmacogenomics (PGx), being the country representative on PGx research for an international group (Global Genomic Medicine Collaborative under the National Institute of Health, USA) and 2 regional groups (including the Southeast Asian Pharmacogenomics Network). PGx is currently one of the fastest growing research area globally and I have supervised over 25 postgraduate students in this field over the years. My laboratory was awarded research funding of over RM3.5 million over a period of 5 years from 2011 to 2015, and our team has published over 105 papers since then. I have been invited to speak on PGx at international and national conferences.  I am also a member of at least 7 committees at the national level, the most significant being the National Committee for Clinical Research (NCCR), chaired by the Director-General of Health, Malaysia. My expertise in Good Clinical Practice (GCP) is recognised, being invited to be a speaker and facilitator at GCP Workshops throughout the country. My expertise also extends to being a consultant for contract research in the form of Bioequivalence (BE) Studies for various generic drug manufacturers since 1999, and to date, we have completed over 32 consultancies.  My Bioequivalence Centre has two accreditations, one under SAMM ISO-IEC 17025/2001, and the other is under Ministry of Health, and is one of only four accredited centres in Malaysia. I was appointed by the Minister of Science, Technology and Innovations, to be a member of the National Bioethics Council (NBC) and presented the Keynote Address at its launch. I have been a Vice-Chairman of NBC. I was also appointed by the Deputy Prime Minister (who was also then the Minister of Education), to be a representive of the University's Senate to the University's Board of Directors, the appointment ended in Dec 2015.  I am also an active member of several NGOs, and frequently and passionately participate in various community and student events.

 

AREAS OF EXPERTISE

  • CLINICAL PHARMACOLOGY
    Pharmacokinetics; Drug Metabolism
  • MOLECULAR PHARMACOLOGY
    Pharmacogenomics; Pharmacogenetics
  • MEDICAL PHARMACOLOGY
    Bioequivalence Studies

ACADEMIC QUALIFICATION

  • PhD(1984), (Pharmacogenomics; Pharmacokinetics; Bioequivalence Studies)
    Dundee University, Scotland
  • BSc(Hons)(Pharmacology)(1979), (FARMAKOLOGI)
    Dundee University, Scotland

ADMINISTRATIVE DUTIES

  • Founding member and Member of the Board of SUCXeS (Shimadzu-University of Malaya Centre for Xenobiotic Services), Faculty of Medicine, University of Malaya
    05 Jul 1999 - present (University Malaya)
  • Head of the Pharmacogenomics Laboratory, Faculty of Medicine. The number of postgraduate students registered in the lab currently is 21.
    03 Dec 2007 - present (Department of Pharmacology, Faculty of Medicine)
  • Principal Investigator of the University of Malaya Bioequivalence and Testing Centre, Faculty of Medicine, University of Malaya (UBAT). Contract research in the form of Bioequivalence Studies have been carried out since 1999 but UBAT has only recently been named so.
    01 Apr 1999 - present (University Malaya)
  • Panel Temuduga Program Ijazah Luar Negara (PILN) 2009 and 2010. Jabatan Perkhidmatan Awam.
    25 Dec 2009 - present (National)
  • Member of the University of Malaya Medical Centre Ethics Committee.
    17 Jan 2011 - present (Department of Pharmacology, Faculty of Medicine)
  • Panel Member of Penilaian Tahap Kecekapan (PTK) Bagi Skim Perkhidmatan Pensyarah Gred 45/51 Tahap Kecekapan (TK) 3 & 4 .
    09 Jan 2006 - present (University Malaya)
  • Panel of auditors for Research Centres of the University of Malaya.
    01 Apr 2009 - present (University Malaya)
  • Panel Member for the Assessment of ERGS Grant 2011 in the field of Medical Science and Clinical.
    27 May 2011 - present (National)
  • National Committee for setting the Malaysian Guidelines to conduct drug-related clinical trials in Malaysia for the Ministry of Health (Guidelines published in June 2000. Currently undergoing revision)
    01 Mar 1999 - present (National)
  • Committee Member for Assessment of Exploratory Research Grant (Health and Clinical Science). Ministry of Higher Education.
    27 May 2011 - present (National)
  • Member of Board of Director of University of Malaya Specialist Centre (UMSC)
    12 Oct 2015 - 12 Oct 2018 (University Malaya)
  • Board member of UM Jana Dana Sdn Bhd, representing UM's Board of Directors (Ahli Lembaga Pengarah UM Jana Dana Sdn Bhd)
    02 Apr 2015 - 02 Apr 2018 (University Malaya)
  • Member of Appeal Panel against Disciplinary Action, University of Malaya Category D, representing UM's Board of Directors (Ahli Jawatankuasa Rayuan Tatatertib Universiti Malaya D)
    02 Apr 2015 - 02 Apr 2018 (University Malaya)
  • Member of the Steering Committee for Development of Health Metropolis University of Malaya (UMHM), representing UM's Board of Directors (Ahli Jawatankuasa bagi Projek Pembangunan Metropolis Perubatan Universiti Malaya)
    02 Apr 2015 - 02 Apr 2018 (University Malaya)
  • Member of Panel for Disciplinary Action for University of Malaya D, representing UM's Board of Directors (Ahli Jawatankuasa Tatatertib Universiti Malaya D),
    02 Apr 2015 - 02 Apr 2018 (University Malaya)
  • Panel member of the Audit Committee of the University of Malaya, representing UM's Board of Directors (Ahli Jawatankuasa Audit Universiti Malaya)
    02 Apr 2015 - 02 Apr 2018 (University Malaya)
  • Panel for Appeal against Student Disciplinary Action, representing UM's Board of Directors (Pengganti Wakil Lembaga ke Jawatankuasa Rayuan Tatatertib Pelajar)
    02 Apr 2015 - 02 Apr 2018 (University Malaya)
  • Member of Board of Directors of UM Capital Berhad (UMCB), representing UM's Board of Directors (Ahli Lembaga Pengarah UM Capital Berhad)
    14 Feb 2014 - 14 Feb 2017 (University Malaya)
  • Member of Board of Directors of UM Capital Berhad (UMCB), representing UM's Board of Directors (Ahli Lembaga Pengarah UM Capital Berhad)
    14 Feb 2014 - 14 Feb 2017 (University Malaya)
  • Council member for the Chair for the Protection of Finance for Aged Citizens (Ahli majlis Kursi Perlindungan Kewangan Warga Tua)
    14 Feb 2014 - 14 Feb 2017 (University Malaya)
  • Member of the Committee for Promotion of Professors representing UM's Board of Directors (Ahli Jawatankuasa Pemilih bagi maksud pelantikan ke suatu Kursi dan Kenaikan Pangkat ke Jawatankuasa Profesor Kanan dan Profesor Gred Khas
    14 Feb 2014 - 14 Feb 2017 (University Malaya)
  • Appointed by the Minister of Education, to represent Senate at the University of Malaya's Board of Directors.
    01 Feb 2014 - 01 Feb 2017 (University Malaya)
  • Head
    01 Jan 2016 - 25 Sep 2016 (University of Malaya Bioequivalance and Testing Centre (Ubat), Faculty of Medicine)
  • Committee Member for Assessment of Research Funds under the Institute of Management and Monitoring of Research (Ahli Jawatankuasa penilaian bagi permohonan geran penyelidikan di bawah tadbir urus IPPP Peringkat UM)
    01 Jan 2015 - 31 Dec 2016 (University Malaya)
  • Head
    01 Jan 2015 - 31 Mar 2015 (University of Malaya Bioequivalance and Testing Centre (Ubat), Faculty of Medicine)
  • Council Member of the National Bioethics Council - extension of term.
    31 Dec 2013 - 31 Dec 2015 (National)
  • Head of Research Centre for the University of Malaya Bioequivalence and Testing Centre (UBAT)
    02 Jan 2014 - 31 Dec 2015 (University Malaya)
  • Head of the University of Malaya Bioequivalence and Testing Centre (UBAT)
    01 Jun 1999 - 31 Dec 2015 (University Malaya)
  • Member of the National Committee for Clinical Research, chaired by the Director-General of Health, Ministry of Health, Malaysia
    01 Jan 2014 - 31 Dec 2015 (National)
  • Senate Member of the University of Malaya
    17 Dec 2012 - 16 Dec 2015 (University Malaya)
  • Senate Representative for UM Staff Application for Conferences
    17 Dec 2012 - 15 Dec 2015 (University Malaya)
  • Vice-Chairman of the National Bioethics Council
    02 Jun 2014 - 01 Jul 2015 (National)
  • Member of Committee for Planning of Human Resource for Faculty of medicine (Ahli Jawatankuasa Perancangan Sumber Manusia bagi Fakulti Perubatan)
    02 Jun 2014 - 30 Jun 2015 (Department of Pharmacology, Faculty of Medicine)
  • Panel of Interviewers for Student Entry into University of Malaya
    14 Mar 2014 - 14 Mar 2015 (University Malaya)
  • Head
    02 Jan 2014 - 31 Dec 2014 (University of Malaya Bioequivalance and Testing Centre (Ubat), Faculty of Medicine)
  • Head of Department
    01 Jul 2014 - 31 Jul 2014 (Department of Pharmacology, Faculty of Medicine)
  • Head of Department
    01 Sep 2012 - 30 Jun 2014 (Department of Pharmacology, Faculty of Medicine)
  • National Committee for Good Laboratory Practice chaired by Professor Dato' Navaratnam. Ministry of Health, Malaysia.
    13 Dec 2004 - 31 Dec 2014 (National)
  • National Committee on Clinical Research, chaired by the Director General of Health. Appointment was by the Ministry of Health, Malaysia. Committee Member since January 1996 till now
    01 Apr 1994 - 31 Dec 2014 (National)
  • National Bioequivalence Committee. Chaired by the Director of the National Pharmaceutical Control Bureau, Ministry of Health. Committee member since its inception in 2004.
    01 Jan 2004 - 31 Dec 2014 (National)
  • Country Representative and member of the Steering Committee for the Asian Network of Pharmacogenomics Research (ANPR)
    07 Jul 2008 - 31 Dec 2014 (International)
  • Panel of Assessors for National Science Foundation Award, Ministry of Science, Technology and Innovations (MOSTI) for 2009 and 2010.
    05 Jan 2009 - 31 Dec 2014 (National)
  • Academic Advisor to MBBS II students for several years including 2008/09, 2009/10, 2010/11, 2011/12, 2012/13
    05 Dec 1994 - 31 Dec 2014 (Department of Pharmacology, Faculty of Medicine)
  • Council Member of the National Bioethics Council (Majlis Bioetika Negara)
    13 Oct 2011 - 31 Dec 2014 (National)
  • Country Representative and Member of the Steering Committee for SEAPharm (Pharmacogenomic Research Network South-East Asia
    01 Jan 2014 - 31 Dec 2014 (International)
  • Panel member of the Health and Translational Research Cluster
    01 Jan 2013 - 31 Dec 2014 (University Malaya)
  • Panel Reviewer/Committee member for Fundamental Research Grant Scheme (FRGS) and Exploratory Research Grant Scheme at UM level
    01 Jan 2013 - 31 Dec 2014 (University Malaya)
  • Head Coordinator
    01 Jan 2014 - 31 Dec 2014 (Department of Pharmacology, Faculty of Medicine)
  • Head of Department of Pharmacology since 1994 till present except for short periods
    01 Feb 1994 - 30 Jun 2014 (University Malaya)
  • Head of Section
    31 Dec 2013 - 31 Jan 2014 (University Malaya)
  • Assessor of the Fundamental Research Grant Scheme (FRGS) at the UM level
    20 Sep 2013 - 20 Sep 2013 (University Malaya)
  • Member of the Medical Centre Research Committee (MCRC)
    01 Nov 2005 - 19 Jul 2013 (University Malaya)
  • Member of the Medical Centre Research Committee (MCRC)
    19 Jul 2013 - 19 Jul 2013 (University Malaya)
  • Senate Representative for Interview of Candidates for University of Malaya's Vice Chancellor from Nov 2013
    10 Jul 2013 - 10 Jul 2013 (National)
  • Assessor for the Exploratory Research Grant Scheme, under the Ministry of Higher Learning
    02 Apr 2013 - 05 Apr 2013 (National)
  • Medical Ethics Committee Member
    10 Oct 2012 - 02 Jan 2013 (University Malaya)
  • Committee Member of the Ethics Committee, representing the Department of Pharmacology
    02 Jan 2013 - 02 Jan 2013 (University Malaya)
  • Head of Department
    01 Jul 2012 - 31 Aug 2012 (Department of Pharmacology, Faculty of Medicine)
  • Head of Department
    09 Jul 2011 - 30 Jun 2012 (Department of Pharmacology, Faculty of Medicine)
  • Panel Reviewer for the Health and Translational Medicine Cluster
    02 Jan 2012 - 31 Dec 2012 (University Malaya)
  • Panel Penilai Pakar untuk Penilaian Pembiayaan Dana Kementerian Sains, Teknologi dan Inovasi. 27 Julai 2010 27 Julai 2012.
    27 Jul 2010 - 27 Jul 2012 (National)
  • Head of Department
    01 Jul 2011 - 08 Jul 2011 (Department of Pharmacology, Faculty of Medicine)
  • Head of Department
    01 Nov 2009 - 30 Jun 2011 (Department of Pharmacology, Faculty of Medicine)
  • National Committee for the revision of the Third Edition of Malaysian Guidelines for Good Clinical Practice. Representing the academicians. The Third Edition was out in January 2011.
    01 Nov 2010 - 17 Jan 2011 (National)
  • Chairman of Judging Committee for PECIPTA, an Inter-University Compettition for Inventions and Innovations organised jointly between UM and Ministry of Higher Education
    02 Feb 2009 - 31 Oct 2009 (National)
  • National Committee Establishment of Standard and Criteria for the Programmes in Traditional and Complementary Medicine, Ministry of Health Malaysia Traditional and Complementary Medicine, Ministry of Health, Malaysia
    01 Jan 2004 - 31 Dec 2008 (National)
  • University of Malaya Committee for the Assessment of Vote F and Fundamental Vote (representing the science-based research). [Jawatankuasa Penyelidikan Jangka Pendek dan Penyelidikan Fundamental Universiti Malaya]
    07 Jan 2002 - 31 Dec 2008 (University Malaya)
  • Committee for Postgraduate Studies of the Faculty of Medicine. Representing the Para-Clinical Departments.
    02 Jan 2007 - 31 Oct 2008 (Department of Pharmacology, Faculty of Medicine)
  • Advisory Committee for Clinical Investigation Centre, University of Malaya Medical Centre
    03 Jan 2000 - 31 Dec 2007 (Department of Pharmacology, Faculty of Medicine)
  • Committee Member of the Animal Ethics Committee of the Faculty of Medicine [ Jawatankuasa Kecil Etika Penjagaan dan Penggunaan Haiwan, Fakulti Perubatan]
    01 Jan 2002 - 30 Dec 2005 (University Malaya)
  • Principal
    05 Dec 1988 - 07 Dec 1992 (University Malaya)
  • President of the University Womens Association for the University of Malaya
    12 Dec 1988 - 18 Dec 1990 (University Malaya)
  • College Secretary
    01 Jan 1986 - 30 Dec 1988 (University Malaya)
  • Honorary Secretary of the Malaysian Biochemical Society
    12 May 1985 - 24 Aug 1987 (National)
  • President of the Malaysian Society of Pharmacology and Physiology
    02 Jan 1984 - 21 Jan 1986 (National)

AWARD AND STEWARDSHIP

  • Keynote Speaker at Postgraduate Seminar at University of Nottingham
    University of Nottingham Malaysia, 2016 (National)
  • Keynote Speaker at the International Symposium on Allied Health Sciences. 5-6th Sept 2015. Kelantan, Malaysia. Title of Talk: Integration of Helath & Technology for Human Well-Being & Ecosystem
    Universiti Sains Malaysia, 2015 (International)
  • Represents Malaysia at the SJS/TEN Standardizing Case Definitions Working Group, which is coordinated by the United States National Institute of Health (NIH) and the National Health Genomics Research Institute (NHGRI)
    United States National Institute of Health (NIH) and the National Health Genomics Research Institute (NHGRI), 2015 (International)
  • Represents Malaysia at the Global Genomic Medicine Cooperative, which is coordinated by the United States' National Institute of Health (NIH) and by the National Health Genomics Research Institute (NHGRI)
    National Institute of Health (NIH) and by the National Health Genomics Research Institute (NHGRI), 2015 (International)
  • Organising Chairman of the Golden Helix Symposia 2015: Next Generation Pharmacogenomics. Kuala Lumpur. 11-13th March 2015. Jointly organised by Golden Helix Foundation and University of Malaya
    Golden Helix Foundation, a foundation based in London, 2015 (International)
  • Invited Facilitator for the Workshop for the Development of a National Code of Conduct for Biosecurity, organised by Science and Technology Research Institute for Defence (STRIDE, Ministry of Defence) and the US Dept of Defence. 3-4th June 2015
    STRIDE, Ministry of Defence, 2015 (International)
  • Invited Speaker for the National Symposium on Ethical Issue in Research II. Title of Lecture is"National Bioethics Council Role in Promoting Ethics in Research Excellence". Also a Panel Member of Forum at same Symposium, entitled "Ethical Scope: Roles and Responsibilities". 19th May 2015
    Universiti Teknologi Mara, 2015 (National)
  • Invited Discussant at Round Table Discussion "Islam and Neuroscience"
    Institut Kefahaman Islam Malaysia, 2014 (International)
  • Invited Speaker for the Monash Health Economics Forum 2014 "Value of Medicines: Patient's and Healthcare Professiona;'s Perspectives
    The School of Pharmacy, Monash University of Malaysia, 2014 (International)
  • Pelantikan Semula Sebagai Ahli Majlis Bioetika Negara 2014
    Menteri Sains, Teknologi dan Inovasi Malysia, 2014 (International)
  • Keynote Speaker of the Pharmacology and Physiology Scientific Congress 14: Title of Talk "Pharmacogenomics Studies in Multiethnic Population". 22-24th Aug 2014.Kuala Lumpur.
    Malaysian Society of Pharmacology and Physiology, 2014 (International)
  • Pharmacology Department, in 2013, heads the list of Departments at the Faculty of Medicine, University of Malaya, Kuala Lumpur, with the most number of publications per staff, and Impact Factor per staff, and Impact Factor per publication
    No formal Award, but a Recognition, 2013 (International)
  • Best Pre-Clinical MBBS Lecturer 2013
    MBBS Final Year Students, 2013 (International)
  • 2012/2013 QS World University Ranking By Subject 2012 Top 51-100 - Pharmacy and Pharmacology
    QS Intelligence Unit, 2013 (International)
  • Invited Speaker for the Symposium on Genetics and and Genome-Guided Personalised Medicine
    Thailand Centre of Excellence and RIKEN, Japan, 2013 (International)
  • Council Member of the Malaysian National Bioethics Council: Re-Appointment
    Ministry of Science, Technology and Innovations, 2013 (National)
  • Accreditation for Bioequivalence Centre from Ministry of Health,for the University of Malaya Bioequivalence and Testing Centre (UBAT), of which I am the Director. One of only 3 centres in Malaysia which were awarded the accreditation.
    National Pharmaceutical Control Bureau, Ministry of Health, 2013 (International)
  • Re-Accreditation ISO/IEC 17025:2005 of the University of Malaya Bioequivalence and Testing Centre (UBAT), of which I am the Director
    Department of Standards Malaysia, Ministry of Science, Technology and Innovations, 2013 (International)
  • Keynote Speaker at Launching of the National Bioethics Council by the Minister of Science, Technology and Innovation
    Ministry of Science, Technology and Innovation, 2012 (International)
  • 2011/2012 QS World Ranking by Subject. UM Pharmacy and Pharmacology Top 51-100
    QS Intelligence Unit, 2012 (International)
  • Expert Panel for Pre-Investigational New Drug Applications
    National Pharmaceutical Control Bureau, Ministry of Health, 2012 (National)
  • Invited Speaker for the 10th Asia Pacific Conference on Human Genetics
    Asia Pacific Society for Human Genetics, 2012 (International)
  • Invited Speaker for 1st Meeting South East Asian Pharmacogenomics Research Network (SEAPharm);Symposium for Genetic and Genome-Guided Personalized Medicine in South East Asia:Overview and Applications Siam City Hotel, Bangkok. February 2-3, 2012
    South East Asian Pharmacogenomics Research Network (SEAPharm), 2012 (International)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2011 (University)
  • Invited Speaker at 1st Malaysia Conference on Rare Disorders and Medical Genetics Conference. Title of Talk " The Pharmacogenomics Approach to Personalised Medicine. 9-10 June 2011
    Malaysian rare Disorders Society and malaysian Genetics Society, 2011 (National)
  • Invited Speaker for 8th Asia-Pacific Medical Education Conference, National University of Singapore. 28th-30th Jan 2012
    NUS, 2011 (International)
  • Keynote Speaker for 2nd Congress of Asian College of Neuropsychopharmacology, Korea. 23-24th Sept 2011
    Korean College of Neuropsychopharmacology, 2011 (International)
  • Invited to be Moderator for Seminar on Perspective on Islam and the West" organised by Institute of Diplomacy and Foreigh Relations Malaysia (IDRF) and Centre of Civilisational Dialogue, UM. 16-17th June 2011
    IDRF and Centre of Civilisational Dialogue, 2011 (National)
  • Keynote Speaker at Malaysian Genome Centre's Eminent Speakers Series
    Malaysian Genome Centre, 2011 (National)
  • Invited Speaker and Facilitator for Good Clinical Practice
    Clinical Investigation Centre, University of Malaya Medical Centre, 2011 (National)
  • Keynote Speaker for 4th Asia Pacific Regional International Society for the Study of Xenobiotics Meeting. 22-25th April 2011 in Tainan, Taiwan.
    International Society for the Study of Xenobiotics (ISSX), 2011 (International)
  • Best Poster Award for the 4th National Conference for Clinical Research 2010 and the 13th National Institutes of Health (NIH) Scientific Meeting. Pharmacogenomic study of carbamazepine in epilepsy in Hospital Kuala Lumpur. S Subenthiran, NR Abdullah, Z Mohamed, JP Joseph, AM Mustaffa and Z Ismail.
    National Institutes of Health, 2010 (International)
  • Excellent Scientist Award 2005 (Saintis Cemerlang 2005). For \"Mitra Kit: The first Mitragynine Test Kit\"
    Ministry of Higher Learning. At the Invention Exhibition of New Invention, Techniques and Products 2005, Geneva., 2010 (International)
  • Awarded second price for best translated science book for 1996. REVIEW OF MEDICAL PHYSIOLOGY by W.F.Ganong. (KAJIAN SEMULA FISIOLOGI PERUBATAN). Translated by Mustafa Ali Mohd, Zurina Ismail & Zahurin Mohamed. 1994. Translation published by Dewan Bahasa dan Pustaka.
    Dewan Bahasa dan Pustaka, 2010 (National)
  • Best Poster for 4th National Conference for Clinical Research 2010 and the 13th National Institute of Health (NIH) Scientific Meeting. June 2010. S Subenthiran, NR Abdullah, Z Mohamed
    National Institute of Health (NIH), 2010 (National)
  • Award of Bionexus Partners (BNP) Programme from Malaysian Biotechnology Corporation for both 2009 and 2010
    Malaysian Biotechnology Corporation, 2010 (National)
  • KHIDMAT SETIA 30 AWARD
    University of Malaya, 2009 (University)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2007 (University)
  • EXCELLENCE SERVICE AWARD
    University of Malaya, 2006 (University)
  • EHM Mohamed, Tan KS, Z. Mohamed, JM Ali, CT Tan. C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene and Increased Plasma Homocysteine Concentration In Ischaemic Stroke. First North-South Workshops on Pharmacogenetics, Kuala Lumpur 12-13 December 2005. Awarded Best Presenter
    USM, 2005 (International)
  • Gold Medal for Invention of Mitra Kit - Test pour reveler la presence de la mitragynine
    Geneva Salon International Des Inventions Geneve, 2005 (International)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2004 (University)
  • Bronze Medal Award for "Bitter Gourd - a potential hypoglycaemic agent" Science and Technology Expo, Malaysia. Aug 2004
    Ministry of Science, Technology and Innovation,, 2004 (National)
  • Awarded Best Scientific Paper. Prevalence of Genetic Polymorphism for 5,10-Methylenetetrahydrofolate Reductase (MTHFR) in Multi Ethnic Malaysian Ischaemic Stroke Population. EHM Mohamed, Tan KS, Z.Mohamed, JM Ali, CT Tan Presented at the Malaysian Society of Neurosciences Annual Scientific Meeting 18th-20th June 2004, Kucing, Sarawak, Malaysia.
    Malaysian Society of Neurosciences, 2004 (National)
  • CERTIFICATE OF EXCELLENT SERVICE
    University of Malaya, 2003 (University)
  • Certificate of Excellent Service for 2003, 2004 and 2007 (Sijil Anugerah Cemerlang bagi 2002, 2003, 2004 dan 2007)
    University of Malaya, 2003 (International)
  • Best Lecturer Award for the MBBS II Year II 1996/97 Session
    Medical Society (MEdSoc) University of Malaya, 1997 (University)

PUBLICATIONS

Article in Journal
  1. Abdulmannan H. Fateh, Zahurin Mohamed, Zamri Chik, Mohammed Abdullah Alshawsh. Prenatal developmental toxicity evaluation of Verbena officinalis during gestation period in female Sprague-Dawley rats. February 2019. Chemico-Biological Interactions 304. DOI: 10.1016/j.cbi.2019.02.016
  2. Abdulmannan H.Fateh, ZahurinMohamed, Zamri Chik, Abdulsamad Alsalahi Siti Rosmani Md Zain, Mohammed A.Alshawsh (2019). Mutagenicity and genotoxicity effects of Verbena officinalis leaves extract in Sprague-Dawley Rats.. Journal of ethnopharmacology. Volume 235, 10 May 2019, Pages 88-99.
  3. Atefehalsadat Seyedan, Zahurin Mohamed, Mustafa Ahmed AL-Shagga, Mohammed Abdullah Alshawsh. Cynometra cauliflora Linn. Attenuates metabolic abnormalities in high-fat diet-induced obese mice (2019) March 2019. Journal of Ethnopharmacology 236 DOI: 10.1016/j.jep.2019.03.00
  4. Sanaz KooshaSanaz Koosha, Zahurin Mohamed, Ajantha Sinniah, Mohammed Abdullah Alshawsh. Investigation into the Molecular Mechanisms underlying the Anti-proliferative and Anti-tumorigenesis activities of Diosmetin against HCT-116 Human Colorectal Cancer (2019). March 2019. Scientific Reports 9(1):5148. DOI: 10.1038/s41598-019-41685-1
  5. Alsalahi, A., Alshawsh, M. A.*, Chik, Z., & Mohamed, Z. (2018). Effect of Catha edulis (khat) on pancreatic functions in streptozotocin-induced diabetes in male Sprague-Dawley rats. Experimental Animals, 2018; 67 (4) 517-526. doi:10.1538/expanim.18-0057
  6. BEHNAZ RIAZALHOSSEINI, ZAHURIN MOHAMED, YAMUNAH DEVI APALASAMY, NOOR SHAFILA SHAFIE and ROSMAWATI MOHAMED (2018) Interleukin-6 gene variants are associated with reduced risk of chronicity in hepatitis B virus infection in a Malaysian population. BIOMEDICAL REPORTS. (2018) DOI: 10.3892/br.2018.1126
  7. Chong, Huey Yi; Lim, Yi Heng; Prawjaeng, Juthamas; et al.Cost-effectiveness analysis of HLA-B*58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population (2018) Pharmacogenetics and Genomics Volume: 28 Issue: 2 Pages: 56-67 Published: FEB 2018. DOI: 10.1097/FPC.0000000000000319
  8. Elham Amini, Mojtaba Golpich, abdoreza soleimani farjam,, Raymond bin Azman Ali,, Zahurin Mohamed. Brain Lipopolysaccharide Preconditioning-Induced Gene Reprogramming Mediates a Tolerance State in Electroconvulsive Shock Model of Epilepsy. May 2018. Frontiers in Pharmacology 9:416. DOI: 10.3389/fphar.2018.00416
  9. Mohd Aizat Mohd Zain, Vijayapandi Pandy, Abu Bakar Abdul Majeed, Zahurin Mohamed. Chronic restraint stress impairs sociability but not social recognition and spatial memory in C57BL/6J mice. November 2018. Experimental Animals 68(1). DOI: 10.1538/expanim.18-0078. LicenseCC BY-NC-ND 4.0
  10. Mojtaba Golpich, Elham Amini, Zahurin Mohamed, Abolhassan Ahmadiani. Reprogramming in inflammatory response to neuronal damage induced by the brain LPS preconditioning: Possible implications in rat model of Parkinson s disease. January 2018. Parkinsonism & Related Disorders 46:e3. DOI: 10.1016/j.parkreldis.2017.11.011
  11. Prevalence of HLA-DQ Alleles and Haplotypes in Patients with Hepatitis B Infection. American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS). (2018) Volume 43, No 1, pp 159-168. ISSN (Online) 2313-4402
  12. Ranjithkumar C, Pandy V*, Mohamed Z (2018). Alpha-asarone attenuates depression-like behavior in nicotine-withdrawn mice: Evidence for the modulation of hippocampal pCREB levels during nicotine-withdrawal. European Journal of Pharmacology, 818, 10-16. https://doi.org/10.1016/j.ejphar.2017.10.025.
  13. Sajad Jamalpour, Shamsul Mohd Zain, Maryam Mosavat, Zahurin Mohamed, Siti Zawiah Omar. A case-control study and meta-analysis confirm glucokinase regulatory gene rs780094 is a risk factor for gestational diabetes mellitus (2018). January 2018. Gene 650(15 April 2018):34 40. DOI: 10.1016/j.gene.2018.01.091
  14. Zaharan NL, Muhamad NH, Jalaludin MY, Su TT, Mohamed Z, Mohamed MNA, Majid HA (2018) Non-synonymous single nucleotide polymorphisms and physical activity interactions on adiposity parameters in Malaysian adolescents. Frontiers in Endocrinology. 9:209. doi: 10.3389/fendo.2018.00209. eCollection 2018
  15. Zain MA, Rouhollahi E, Pandy V*, Mani V, Majeed ABA, Wong WF, Mohamed Z (2018). Phencyclidine dose optimisation for induction of spatial learning and memory deficits related to schizophrenia in C57BL/6 mice. Exp. Anim. 67(4), 421 429.
  16. Zain, M. A., Zainal, N. Z., Kanagasundram, S. and Mohamed, Z. (2018) Genetic association study of PDLIM5 and HTR2A variants in Malaysian subjects diagnosed with bipolar disorder; a genetic modelling approach , Neuroscience Research Notes, 1(1), pp. 11-20. doi: 10.31117/neuroscirn.v1i1.9.
  17. Zin, Siti Rosmani Md; Mohamed, Zahurin; Alshawsh, Mohammed ; Wong, Won; Kassim, Normadiah. Mutagenicity evaluation of Anastatica hierochuntica L. aqueous extract in vitro and in vivo. Experimental Biology and Medicine Volume: 243 Issue: 4 Pages: 375-385 Published: FEB 2018. DOI: 10.1177/1535370217748574
  18. Behnaz Riazalhosseini, Rosmawati Mohamed, Devi Apalasamy, Mbongo Langmia, Zahurin Mohamed: Circulating microRNA as a marker for predicting liver disease progression in patients with chronic hepatitis B. Revista da Sociedade Brasileira de Medicina Tropical 04/2017; 50(2):161-166., DOI:10.1590/0037-8682-0416-2016
  19. Chong HY, Mohamed Z, Tan LL, Wu DB, Shabaruddin FH, Dahlui M, Apalasamy YD, Snyder SR, Williams MS, Hao J, Cavallari LH & Chaiyakunapruk N (2017) Is Universal HLA-B*15:02 Screening a Cost-Effective Option in an Ethnically-Diverse Population? A Case Study of Malaysia. British Journal of Dermatology 177(4):1102-1112 doi: 10.1111/bjd.15498
  20. Evaluation of pharmacokinetics and Blood-Brain Barrier permeability of mitragynine using in vivo microdialysis technique. Wai Mun Kong, Zahurin Mohamed, Mohammed AL Shawsh, Zamri Chik.Journal of Pharmaceutical and Biomedical Analysis. Volume 143 (43-47), 2017
  21. Huey Yi Chong, Yi Heng Lim, Juthamas Prawjaeng, Tassaneeyakul Wichittra, Zahurin Mohamed and Nathorn Chaiyakunapruk. Cost-effectiveness analysis of HLA-B*58:01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens Johnson syndrome/toxic epidermal necrolysis in a Malaysian population. Pharmacogenetics and Genomics, Nov 2017, DOI10.1097/FPC.0000000000000319
  22. Mirazul Islam, Zahurin Mohamed, Yassen Assenov: Differential Analysis of Genetic, Epigenetic, and Cytogenetic Abnormalities in AML. International Journal of Genomics 06/2017; 2017(Article ID 2913648):13., DOI:10.1155/2017/2913648
  23. Narasingam M, Vijeepallam K, Mohamed Z, Pandy V* (2017). Anxiolytic- and antidepressant-like activities of a methanolic extract of Morinda citrifolia Linn. (noni) fruit in mice: Involvement of benzodiazepine-GABAAergic, serotonergic and adrenergic systems. Biomedicine & Pharmacotherapy 96, 944-952.
  24. Pandy V*, Narasingam M, Vijeepallam K, Mohan S, Mani V, and Mohamed Z (2017). Ethyl acetate fractionate of methanolic extract of noni (Morinda citrifolia Linn.) unripe fruit exhibits a biphasic effect on dopaminergic system in mice. Experimental Animals 66(3), 283-291.
  25. Prevathe Poniah, Shamsul Mohd Zain, Azad Hassan Abdul Razack, Shanggar Kuppusamy, Shankar Karuppayah, Hooi Sian Eng, Zahurin Mohamed: Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer. Urologic Oncology 05/2017;, DOI:10.1016/j.urolonc.2017.04.017
  26. Rahmadhani, R., Zaharan, N. L., Mohamed, Z., Moy, F. M., & Jalaludin, M. Y. (2017). The associations between VDR BsmI polymorphisms and risk of vitamin D deficiency, obesity and insulin resistance in adolescents residing in a tropical country. PLoS One, 12(6), e0178695. doi: 10.1371/journal.pone.0178695
  27. Ranjithkumar C, Pandy V*, Mohamed Z. (2017). Pharmacology and Toxicology of - and - Asarone: A Review of Preclinical Evidence. Phytomedicine 32, 41-58
  28. Sim M S, Soga T, Pandy V, Wu Y S, Parhar I S, and Mohamed Z (2017). MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens. Metabolic Brain Disease, 1-17. doi:10.1007/s11011-017-0061-x
  29. Sim MS, Soga T, Pandy V, Wu YS, Parhar IS, Mohamed Z. (2017) MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens. Metab Brain Dis., 32(6):1767-1783. (Impact factor: 2.297)
  30. Ten, L. C., Chin, Y. M., Tai, M. C., Chin, E. F. M., Lim, Y. Y., Suthandiram, S., ... & Gan, G. G. (2017). SNP variants associated with non-Hodgkin lymphoma (NHL) correlate with human leukocyte antigen (HLA) class II expression. Scientific Reports, 7.
  31. Wai Mun Kong, Zamri Chik, Zahurin Mohamed, Mohammed A Alshawsh: Physicochemical Characterization of Mitragyna speciosa Alkaloid Extract and Mitragynine Using In Vitro High Throughput Assays. Combinatorial chemistry & high throughput screening 10/2017; 20, DOI:10.2174/1386207320666171026121820
  32. Zin, S. R. M., Kassim, N. M., Alshawsh, M. A., Hashim, N. E., & Mohamed, Z. (2017). Biological activities of Anastatica hierochuntica L.: A systematic review. Biomedicine & Pharmacotherapy, 91, 611-620.
  33. Abdulsamad Alsalahi, Mohammed A. Alshawsh*, Rosmawati Mohamed, Naelah A. Alyousefi, Mustafa Ahmed Alshagga, Abdrabuh N Shwter, Ali Al-Maqtari, Radwan H. Ahmed and Zahurin Mohamed*. Conflicting Reports on the Role of the Glycemic Effect of Catha edulis (Khat): A Systematic Review and Meta- analysis. Journal of Ethnopharmacology (2016); Impact Factor 2.9999.
  34. Atefehalsadat Seyedan, Mohammed Abdullah Alshawsh, Mustafa Ahmed Alshagga, Zahurin Mohamed: Antiobesity and Lipid Lowering Effects of Orthosiphon stamineus in High-Fat Diet-Induced Obese Mice. Planta Medica 12/2016;, DOI:10.1055/s-0042-121754
  35. Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway. Subramaniam KS, Omar IS, Kwong SC, Mohamed Z, Woo YL, Mat Adenan NA, Chung I. Am J Cancer Res. 2016 Jan 15;6(2):200-13. eCollection 2016
  36. Chellian Ranjith Kumar, Vijayapandi Pandy, Zahurin Mohamed. Biphasic effects of -asarone on immobility in the tail suspension test: Evidence for the involvement of the noradrenergic and serotonergic systems in its antidepressant-like activity. FRONTIERS IN PHARMACOLOGY MARCH 2016. Impact Factor: 3.80 DOI: 10.3389/fphar.2016.00072
  37. Chellian Ranjith Kumar, Vijayapandi Pandy, Zahurin Mohamed: Biphasic Effects of -Asarone on Immobility in the Tail Suspension Test: Evidence for the Involvement of the Noradrenergic and Serotonergic Systems in Its Antidepressant-Like Activity. Frontiers in Pharmacology 03/2016; 7(20120537)., DOI:10.3389/fphar.2016.00072
  38. D. A. Loh, F. M. Moy, N. L. Zaharan, M. Y. Jalaludin and Z. Mohamed. 2016. Sugar-sweetened beverage intake and its associations with cardiometabolic risks among adolescents. Pediatric Obesity. doi:10.1111/ijpo.12108
  39. Debbie Ann Loh, Foong Ming Moy, Nur Lisa Zaharan, Muhammad Yazid Jalaludin, Zahurin Mohamed. Sugar- sweetened beverage intake and its associations with cardiometabolic risks among adolescents. PEDIATRIC OBESITY FEBRUARY 2016. Impact Factor: 4.57 DOI: 10.1111/ijpo.12108
  40. Elnaz Bakhtiyari, Mohammad Mahdi Ahmadian-Attari, Peyman Salehi, Behzad Khallaghi, Leila Dargahi, Zahurin Mohamed, Mohammad Kamalinejad, Abolhassan Ahmadiani: Non-polyphenolic compounds of a specific kind of dried grape (Maviz) inhibit memory impairments induced by beta-amyloid peptide. Nutritional Neuroscience 05/2016;, DOI:10.1080/1028415X.2016.1183986
  41. Immaculate M. Langmia, Yamunah D. Apalasamy, Siti O. Zawiah, Zahurin Mohamed: Impact of IL1B gene polymorphisms and interleukin 1B levels on susceptibility to spontaneous preterm birth. Pharmacogenetics and Genomics 09/2016;, DOI:10.1097/FPC.0000000000000243
  42. Lim CH, Zainal NZ, Kanagasundram S, Zain SM, Mohamed Z. Preliminary examination of microRNA expression profiling in bipolar disorder I patients during antipsychotic treatment. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 2016; 171(6):867-74.
  43. Ling JC, Mohamed MN, Jalaludin MY, Rampal S, Zaharan NL, Mohamed Z (2016).Determinants of High Fasting Insulin and Insulin Resistance Among Overweight/Obese Adolescents. Sci Rep 6:36270.
  44. Megala Narasingam, Vijayapandi Pandy*, Zahurin Mohamed. Noni (Morinda citrifolia L.) fruit extract attenuates the rewarding effect of heroin in conditioned place preference but not withdrawal in rodents. EXPERIMENTAL ANIMALS JANUARY 2016. Impact Factor: 0.97 DOI: 10.1538/expanim.15-0088
  45. Mojtaba Golpich, Elham Amini, Zahurin Mohamed, Raymond Azman Ali, Norlinah Mohamed Ibrahim, Abolhassan Ahmadiani: Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment. CNS Neuroscience & Therapeutics 11/2016; 23(11):1-18., DOI:10.1111/cns.12655
  46. Mustafa Ahmed Alshagga, Mohammed Abdullah Alshawsh, Atefehalsadat Seyedan, Abdulsamad Alsalahi, Yan Pan, Suresh Kumar Mohankumar, Abdolgodose Alkebsi, Saba Kassim, Zahurin Mohamed: Khat (Catha edulis) and Obesity: A Scoping Review of Animal and Human Studies. Annals of Nutrition and Metabolism 11/2016; 69(3-4):200-211., DOI:10.1159/000452895
  47. R.M. Guad, N.L. Zaharan, Z. Chik, Z. Mohamed, B.S. Haerian, K.P. Ng, W.A.H. Wan Md Adnan. Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients. TRANSPLANTATION PROCEEDINGS 48(1):81-87 FEBRUARY 2016. Impact Factor: 0.98 DOI: 10.1016/j.transproceed.2016.01.001
  48. Sanaz Koosha, Mohammed A. Alshawsh, Looi Chung Yeng, Atefehalsadat Seyedan and Zahurin Mohamed. An Association Map on the Effect of Flavonoids on the Signaling Pathways in Colorectal Cancer. International Journal of Medical Sciences 2016.
  49. Abdul Halim-Fikri Hashim, Ali Etemad, Ahmad Zubaidi Abdul Latif, Amir Feisal Merican, Atif Amin Baig, Azlina Ahmad Annuar, Endom Ismail Iman Salahshourifar, Liza Sharmini Ahmad Tajudin Marini Ramli, Rosnah Binti Zain, Shafini Mohamed Yusoff, Surini Yusoff, Tan Soon Guan, Thong Meow Keong, Hatin Wan-Isa, Wan Zaidah Abdullah, Zahurin Mohamed, Zarina Abdul Latiff, Bin Alwi Zilfalil. The first Malay database toward the ethnic-specific target molecular variation. BMC RESEARCH NOTES 8(1):176 APRIL 2015 with 182 READS DOI: 10.1186/s13104-015-1123-y Source: PubMed
  50. Apalasamy YD, Ming MF, Rampal S, Bulgiba A, Mohamed Z. Gender-Dependent Association of a 2- Adrenergic Gene Variant With Obesity Parameters in Malaysian Malays. Asia Pac J Public Health. 2015 Mar;27(2):NP154-65. PMID: 22199155. Impact Factor: 1.11
  51. Apalasamy YD, Rampal S, Salim A, Moy FM, Su TT, Majid HA, Bulgiba A, Mohamed Z. Polymorphisms of the resistin gene and their association with obesity and resistin levels in Malaysian Malays. Biochem Genet. 2015 Jun;53(4-6):120-31. PMID: 25991560
  52. Atefehalsadat Seyedan, Mohammed A. Alshawsh, Mustafa Ahmed Mahdi Al-Shagga, Sanaz Koosha and Zahurin Mohamed. Medicinal Plants and Their Inhibitory Activities Against Pancreatic Lipase: A Review" by Evidence-Based Complementary and Alternative Medicine. Impact Factor = 1.88
  53. Batoul Sadat Haerian, Hidayati Mohd Sha'ari, Hui Jan Tan, Choong Yi Fong, Sau Wei Wong, Lai Choo Ong, Azman Ali Raymond, Chong Tin Tan, Zahurin Mohamed. RORA gene rs12912233 and rs880626 polymorphisms and their interaction with SCN1A rs3812718 in the risk of epilepsy: A case control study in Malaysia. GENOMICS 105(4) FEBRUARY 2015. Impact Factor: 2.79 DOI: 10.1016/j.ygeno.2015.02.001
  54. Batoul Sadat Haerian, Larry Baum, Patrick Kwan, Stacey S. Cherny, Jae-Gook Shin, Sung Eun Kim, Bok- Ghee Han7 & Hui Jun Tan, Azman Ali Raymond, Chong Tin Tan, Zahurin Mohamed. Contribution of GABRG2 Polymorphisms to Risk of Epilepsy and Febrile Seizure: a Multicenter Cohort Study and Meta- analysis. Molecular Neurobiology 2015. (Tier 1; Impact Factor = 5.137).DOI: 10.1007/s12035-015-9457- y
  55. Batoul Sadat Haerian, Larry Baum, Patrick Kwan, Stacey S. Cherny, Jae-Gook Shin, Sung Eun Kim, Bok- Ghee Han, Hui Jun Tan, Azman Ali Raymond, Chong Tin Tan, Zahurin Mohamed. Contribution of GABRG2 Polymorphisms to Risk of Epilepsy and Febrile Seizure: a Multicenter Cohort Study and Meta- analysis. MOLECULAR NEUROBIOLOGY OCTOBER 2015. DOI: 10.1007/s12035-015-9457-y. (Impact Factor 5.14)
  56. Behnaz Riazalhosseini, Zahurin Mohamed, Yamunah Devi Apalasamy, Rosmawati Mohamed. Association between microRNA-196A2 and microRNA-146A polymorphisms and progression to cirrhosis and hepatocellular carcinoma in patients with viral hepatitis B. Pharmacogenetics and Genomics 2015. (Tier 1; Impact Factor = 3.481) DOI: 10.1097/FPC.0000000000000187
  57. D A Loh, F M Moy, N L Zaharan, Z Mohamed. Disparities in health-related quality of life among healthy adolescents in a developing country the impact of gender, ethnicity, socio-economic status and weight status. Child Care Health and Development 04/2015; DOI:10.1111/cch.12252 .Impact Factor: 1.83
  58. Elham Rouhollahi, Soheil Zorofchian Moghadamtousi, Fatemeh Hajiaghaalipour, Salma Baig, Faezeh Tayeby, Maryam Zahedifard, Mahmood Ameen Abdulla, Zahurin Mohamed. Curcuma purpurascens BI. rhizome accelerates rat excisional wound healing; involvement of HSP70/Bax proteins, antioxidant defence and angiogenesis activity.Drug Design Development and Therapy 2015. Oct 27;9:5805-13. doi: 10.2147/DDDT.S88196. eCollection 2015. Impact Factor 3.028.
  59. Elham Rouhollahi, Soheil Zorofchian Moghadamtousi, Mohammadjavad Paydar, Mehran Fadaeinasab, Maryam Zahedifard, Maryam Hajrezaie, Omer Abdalla Ahmed Hamdi, Chung Yeng Looi, Mahmood Ameen Abdulla, Khalijah Awang, Zahurin Mohamed. Inhibitory effect of Curcuma purpurascens BI. rhizome on HT-29 colon cancer cells through mitochondrial-dependent apoptosis pathway. BMC Complementary and Alternative Medicine 02/2015; 15(1):15. FEBRUARY 2015 Impact Factor: 1.88 DOI: 10.1186/s12906-015-0534-6
  60. Elham Rouhollahi, Soheil Zorofchian Moghadamtousi, Mohammadjavad Paydar, Mehran Fadaeinasab, Maryam Zahedifard, Maryam Hajrezaie, Omer Abdalla Ahmed Hamdi, Chung Yeng Looi, Mahmood Ameen Abdulla, Khalijah Awang, Zahurin Mohamed. Inhibitory effect of Curcuma purpurascens BI. rhizome on HT-29 colon cancer cells through mitochondrial-dependent apoptosis pathway. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 15(1):15 FEBRUARY 2015 Impact Factor: 1.88 DOI: 10.1186/s12906-015-0534-6
  61. Golpich M, Amini E, Hemmati F, Ibrahim NM, Rahmani B, Mohamed Z, Raymond AA, Dargahi L, Ghasemi R, Ahmadiani A. Glycogen synthase kinase-3 beta (GSK- 3 ) signaling: Implications for Parkinson's disease PHARMACOLOGICAL RESEARCH MARCH 2015, Impact Factor: 4.41 . DOI: 10.1016/j.phrs.2015.03.010
  62. Golpich, M., Amini, E., Hemmati, F., Ibrahim, N. M., Mohamed, Z., Raymond, A. A., Dargahi, L., Ghasemi, R., & Ahmadiani, A. (2015). Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease. Pharmacological Research. 1-30. DOI:10.1016/j.phrs.2015.03.010
  63. Hidayati Mohd Sha ari, Batoul Sadat Haerian, Larry Baum, Hui Jan Tan, Mohd Hanip Rafia, Patrick Kwan, Stacey S. Cherny, Pak Chung Sham, Hongsheng Gui, Azman Ali Raymond, Kheng Seang Lim, Zahurin Mohamed. Association of BDNF Polymorphisms with the Risk of Epilepsy: a Multicenter Study. MOLECULAR NEUROBIOLOGY APRIL 2015. Impact Factor: 5.29 DOI: 10.1007/s12035-015-9150-1
  64. Hwa-li Tan, Rosmawati Mohamed, Zahurin Mohamed, Shamsul Mohd Zain. Phosphatidylethanolamine N- methyltransferase gene rs7946 polymorphism plays a role in risk of non-alcoholic fatty liver disease: Evidence from meta-analysis. Pharmacogenetics and Genomics 2015. Impact Factor 3.48 . DOI: 10.1097/FPC.0000000000000193
  65. I M Langmia, Y D Apalasamy, S Z Suki, S Z Omar, Z Mohamed. Genetic association of AKAP10 gene polymorphism with reduced risk of preterm birth JOURNAL OF PERINATOLOGY JUNE 2015. Impact Factor: 2.35 DOI: 10.1038/jp.2015.68. http://www.nature.com/jp/journal/vaop/ncurrent/pdf/j p201568a.pdf
  66. Immaculate Mbongo Langmia, Yamunah Devi Apalasamy, Siti Zawaih Omar, Zahurin Mohamed. Progesterone Receptor (PGR) gene polymorphism is associated with susceptibility to preterm birth. BMC Medical Genetics 08/2015; 16(1). DOI:10.1186/s12881-015- 0202-1, 2.08 Impact Factor
  67. Immaculate Mbongo Langmia, Yamunah Devi Apalasamy, Siti Zawiah Omar, Zahurin Mohamed. Interleukin 1 receptor type 2 gene polymorphism is associated with reduced risk of preterm birth. The Journal of Maternal-Fetal & Neonatal Medicine 2015. DOI:10.3109/14767058.2015.1125466.Impact Factor = 1.367.
  68. Konstantinos Mitropoulos, Hayat Al Jaibeji, Diego A Forero, Paul Laissue, Ambroise Wonkam, Catalina Lopez-Correa, Zahurin Mohamed, Wasun Chantratita, Ming Ta Michael Lee, Adrian Llerena, Angela Brand, Bassam R Ali, George P Patrinos. Success stories in genomic medicine from resource-limited countries. Human genomics 06/2015; 9(1):11. DOI:10.1186/s40246- 015-0033-3 2.15 Impact Factor
  69. Langmia IM, Apalasamy YD, Omar SZ, Mohamed Z. Association of VEGFA gene polymorphisms and VEGFA plasma levels with spontaneous preterm birth. Pharmacogenetics and Genomics 2015 Apr;25(4):199-204 (3.45 Impact Factor) DOI: 10.1097/FPC.0000000000000125 ,
  70. Langmia Immaculate Mbongo, Apalasamy Yamunah Devi, Shamsul Zain, Siti Zawiah Omar, Zahurin Mohamed (2015.Protein Profiling of Women with Spontaneous Preterm Birth. Pharmacology 06/2015; 96(1-2):44-48. DOI:10.1159/000430857 1.58 Impact Factor
  71. Loh, D. A., Moy, F. M., Zaharan, N. L., & Mohamed, Z. (2015). Disparities in health-related quality of life among healthy adolescents in a developing country - the impact of gender, ethnicity, socio- economic status and weight status. Child Care Health Dev, 15(10). April 2015. Impact Factor: 1.83 DOI: 10.1111/cch.12252
  72. MM Islam, M Aktaruzzaman, Z Mohamed. Comparative sequence-structure analysis of Aves insulin. Bioinformation 11(2): 067-072 (2015) 0.50 Impact Factor. Published February 28, 2015; ISSN 0973-2063 (online) 0973-8894 (print)
  73. Md. Mirazul Islam and Zahurin Mohamed Computational and Pharmacological Target of Neurovascular Unit for Drug Design and Delivery. BioMed Research International 10/2015; 2015(480). DOI:10.1155/2015/731292 2.71 Impact Factor
  74. Megala Narasingam, Vijayapandi Pandy, Zahurin Mohamed. Noni (Morinda citrifolia L.) fruit extract attenuates the rewarding effect of heroin in conditioned place preference but not withdrawal in rodents. Experimental Animals 2015.
  75. Nur Elia Nazree, Ai Chin Loke, Nor Zuraida Zainal, Zahurin Mohamed. 2015. Lack of association between TPH2 gene polymorphisms with major depressive disorder in multiethnic Malaysian population. ASIA- PACIFIC PSYCHIATRY 7 (1), pp. 72-77 DOI: 10.1111/appy.12118
  76. Nur Elia Nazree, Zahurin Mohamed, Gavin P. Reynolds, Shamsul Mohd Zain, Ruziana Masiran, Hattaa Sidi, Lu Ann Chong, Ann Yee Hway, Aida Syarinaz Adlan, Nor Zuraida Zainal. Association of brain-derived neurotrophic factor valine to methionine polymorphism with sexual dysfunction following selective serotonin reuptake inhibitor treatment in female patients with major depressive disorder Asia-Pacific Psychiatry 09/2015; DOI:10.1111/appy.12210 0.63 Impact Factor
  77. Polin Haghvirdizadeh, Zahurin Mohamed, Nor Azizan Abdullah, Pantea Haghvirdizadeh, Monir Sadat Haerian, Batoul Sadat Haerian. KCNJ11: Genetic Polymorphisms and Risk of Diabetes Mellitus. EXPERIMENTAL DIABETES RESEARCH JANUARY 2015 Impact Factor: 3.54 DOI: 10.1155/2014/908152
  78. Prevathe Poniah, Zahurin Mohamed, Yamunah Devi Apalasamy, Shamsul Mohd Zain, Shanggar Kuppusamy, Azad Hassan Abdul Razack. Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups. International Journal of Clinical and Experimental Medicine (IJCEM) 2015. Impact Factor = 1.277
  79. Rouhollahi E, Moghadamtousi SZ, Al-Henhena N, Kunasegaran T, Hasanpourghadi M, Looi CY, Abd Malek SN, Awang K, Abdulla MA, Mohamed Z.The chemopreventive potential of Curcuma purpurascens rhizome in reducing azoxymethane-induced aberrant crypt foci in rats. DRUG DESIGN, DEVELOPMENT AND THERAPY 9:3911-3922 JULY 2015 Impact Factor: 3.03 DOI: 10.2147/DDDT.S84560
  80. Seyedeh Masoumeh Seyedhoseini Tamijani1, Benyamin Karimi, Elham Amini,Mojtaba Golpich, Leila Dargahi, Raymond Azman Ali, Norlinah Mohamed Ibrahim,ZahurinMohamed, Rasoul Ghasemi, Abolhassan Ahmadiani. Thyroid hormones: possible roles in epilepsy pathology. SEIZURE AUGUST 2015. Impact Factor: 2.06 DOI: 10.1016/j.seizure.2015.07.021
  81. Shamsul Mohd Zain, Zahurin Mohameda, Muhammad Yazid Jalaludin, Fatin Fauzia, Anahita Hamidia, Nur Lisa Zaharan. Comprehensive evaluation of the neuropeptide-y gene variants in risk of obesity: A case-control study and meta-analysis. Comprehensive evaluation of the neuropeptide-Y gene variants in the risk of obesity: a case-control study and meta- analysis. PHARMACOGENETICS AND GENOMICS AUGUST 2015. Impact Factor: 3.45 DOI: 10.1097/FPC.0000000000000164
  82. Yamunah Devi Apalasamy and Zahurin Mohamed. Obesity and genomics: role of technology in unraveling the complex genetic architecture of obesity. HUMAN GENETICS FEBRUARY 2015. Impact Factor: 4.52 DOI: 10.1007/s00439-015-1533-x
  83. Zain SM, Mohamed Z, Pirmohamed M, Tan HL, Alshawsh MA, Mahadeva S, Chan WK, Mustapha NR, Mohamed R. Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non-alcoholic fatty liver disease. Scientific Reports 2015. Impact Factor 5.578. Sci Rep. 2015 Aug 21;5:13306. doi: 10.1038/srep13306.
  84. Batoul Sadat Haerian, Hidayati Mohd Sha'ari, Choong Yi Fong, Hui Jan Tan, Sau Wei Wong, Ong Lai Choong, Azman Ali Raymond, Chong Tin Tan, Zahurin Mohamed. Contribution of TIMP4 rs3755724 polymorphism to susceptibility to focal epilepsy in Malaysian Chinese. JOURNAL OF NEUROIMMUNOLOGY 2015, 278; 137- 143 DECEMBER 2014. Impact Factor: 2.79 DOI: 10.1016/j.jneuroim.2014.12.016
  85. Batoul Sadat Haerian, Hidayati Mohd Sha'ari, Choong Yi Fong, Hui Jan Tan, Sau Wei Wong, Ong Lai Choong, Azman Ali Raymond, Chong Tin Tan, Zahurin Mohamed. Contribution of TIMP4 rs3755724 polymorphism to susceptibility to focal epilepsy in Malaysian Chinese. Journal of Neuroimmunology 12/2014; 278. 2.79 Impact Factor
  86. Chor Hong Lim, Shamsul Mohd Zain, Gavin Reynolds, Siti Norsyuhada Mohd Roffeei, Mohd Aizat Mohd Zain, Sharmilla Kanagasundram; Nor Zuraida Zainal, Zahurin Mohamed. Genetic association of LMAN2L gene in schizophrenia and bipolar disorder and its interaction with ANK3 gene polymorphism. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY 24 JUNE 2014, Impact Factor: 4.03 DOI: 10.1016/j.pnpbp.2014.05.017
  87. Elham Amini, Golpich Mojtaba, Rasoul Ghasemi, Zahurin Mohamed, Norlinah Ibrahim Azman Ali Raymond (2014). A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts. MOLECULAR NEUROBIOLOGY SEPTEMBER 2014 Impact Factor: 5.29 DOI: 10.1007/s12035-014-8876-5
  88. Elham Rouhollahi, Soheil Zorofchian Moghadamtousi, Omer Abdalla Ahmed Hamdi, Mehran Fadaeinasab, Maryam Hajrezaie, Khalijah Binti Awang, Chung Yeng Looi, Mahmood Ameen Abdulla and Zahurin Mohamed.Evaluation of acute toxicity and gastroprotective activity of curcuma purpurascens BI. rhizome against ethanol- induced gastric mucosal injury in rats (2014). BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 14(1):378 OCTOBER 2014, Impact Factor: 1.88 DOI: 10.1186/1472-6882-14-378
  89. Fatemeh Hemmati, Rasoul Ghasemi, Leila Dargahi, Zahurin Mohamed, Azman Ali Raymond, Norlinah Mohamed Ibrahim, Abolhassan Ahmadiani. Crosstalk between insulin and toll-like receptors signaling pathways. MOLECULAR NEUROBIOLOGY 50(3) JANUARY 2014 Impact Factor: 5.29 DOI: 10.1007/s12035-013-8631-3
  90. Hidayati Mohd Shaari, Batoul Sadat Haerian, Larry Baum, Junji Saruwatari, Hui Jan Tan, Mohd Hanip Rafia, Azman Ali Raymond, Patrick Kwan, Takateru Ishitsu, Kazuko Nakagawa,Kheng Seang Lim, Zahurin Mohamed. ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to anti- epileptic drugs in Asia Pacific epilepsy cohorts. PHARMACOGENOMICS 15(4):459-66 MARCH 2014 Impact Factor: 3.43 DOI: 10.2217/pgs.13.239
  91. Larry Baum, Batoul Sadat Haerian , Ho Keung Ng, Virginia C. N. Wong, Ping Wing Ng, Colin H. T. Lui, Ngai Chuen Sin, Chunbo Zhang, Brian Tomlinson, Gary Wing Kin Wong, Hui Jan Tan, Azman Ali Raymond, Zahurin Mohamed, Patrick Kwan. Case control association study of polymorphisms in the voltage- gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy. HUMAN GENETICS 133(5):651-659 MAY 2014 Impact Factor: 4.52 DOI: 10.1007/s00439-013-1405-1
  92. M.S. Sim*, A. Hatim, S.H. Diong, Z. Mohamed. Genetic Polymorphism in DTNBP1 Gene Is Associated With Methamphetamine-Induced Panic Disorder. JOURNAL OF ADDICTION MEDICINE OCTOBER 2014 Impact Factor: 1.71 DOI: 10.1097/ADM.0000000000000075
  93. Minoo Haerian, Larry Baum, Patrick Kwan, Stacey Cherny, Hui Jan Tan, Raymond bin Azman Ali, Zahurin Mohamed. Association of GABRG2 rs211037 polymorphism with susceptibility to epilepsy in Asians: a multicentre cohort study and meta-analysis. THE FASEB JOURNAL 28:912.8 APRIL 2014. Impact Factor: 5.48
  94. Mohd A. Zain, Siti N. Roffeei, Nor Z. Zainal, Sharmilla Kanagasundram and Zahurin Mohamed. Nonsynonymous polymorphisms of the PDLIM5 gene association with the occurrence of both bipolar disorder and schizophrenia. PSYCHIATRIC GENETICS 23(6) SEPTEMBER 2013. Impact Factor: 2.27 DOI: 10.1097/YPG.0000000000000015
  95. Mojtaba Golpich, Behrouz Rahmani, Leila Dragahi, Raymond Azman Ali, Norlinah Mohd Ibrahim, Zahurin Mohamed, Abolhassan Ahmadiani. Preconditioning as a Potential Strategy for the Prevention of Parkinson s Disease. MOLECULAR NEUROBIOLOGY 51(1) APRIL 2014 Impact Factor: 5.29 DOI: 10.1007/s12035-014-8689-6 . Tier 1
  96. Rana Omidbakhsh, Banafshe Rajabli, Sanaz Nasoohi, Behzad Khallaghi, Zahurin Mohamed, Murali Naidu, Abolhassan Ahmadiani1, Leila Dargahi(2014). Fingolimod affects gene expression profile associated with LPS- induced memory impairment. EXPERIMENTAL BRAIN RESEARCH JULY 2014 Impact Factor: 2.17 DOI: 10.1007/s00221-014-4052-4
  97. Ruziana Masiran, Hatta Sidi, Zahurin Mohamed, Nur Elia Mohd Nazree, Nik Ruzyanei Nik Jaafar, Marhani Midin, Srijit Das, Suriati Mohamed Saini (2014). Female Sexual Dysfunction in Patients with Major Depressive Disorder (MDD) Treated with Selective Serotonin Reuptake Inhibitor (SSRI) and Its Association with Serotonin 2A- 1438 G/A Single Nucleotide Polymorphisms. Journal of Sexual Medicine 2014; 11:1047-1055. DOI:10.1111/jsm.12452. (Impact Factor: 3.51)
  98. Ruziana Masiran, Hatta Sidi, Zahurin Mohamed, Nur Elia Mohd. Nazree, Nik Ruzyanei Nik Jaafar, Marhani Midin, Srijit Das, Suriati Mohamed Saini. Female Sexual Dysfunction in Patients with Major Depressive Disorder (MDD) Treated with Selective Serotonin Reuptake Inhibitor (SSRI) and Its Association with Serotonin 2A-1438 G/A Single Nucleotide Polymorphisms. JOURNAL OF SEXUAL MEDICINE 11(4) FEBRUARY 2014 Impact Factor: 3.15 DOI: 10.1111/jsm.12452
  99. Shamsul Mohd Zain, Rosmawati Mohamed, David N. Cooper, Rozaimi Razali, Sanjay Rampal, Sanjiv Mahadeva, Wah- Kheong Chan, Arif Anwar, Nurul Shielawati Mohamed Rosli, Anis Shafina Mahfudz Phaik-Leng Cheah Roma Choudhury Basu,9 and Zahurin Mohamed1,2. Genome-Wide Analysis of Copy Number Variation Identifies Candidate Gene Loci Associated with the Progression of Non-Alcoholic Fatty Liver Disease. PLOS ONE 9(4):E95604 APRIL 2014 Northeast Ohio Medical University, United States of America. Impact Factor: 3.53 DOI: 10.1371/journal.pone.0095604
  100. Shamsul Mohd Zain, Zahurin Mohamed, Rosmawati Mohamed. A common variant in the glucokinase regulatory gene rs780094 and risk of non-alcoholic fatty liver disease: A meta-analysis. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 30(1) AUGUST 2014 Impact Factor: 3.63 DOI: 10.1111/jgh.12714
  101. Shiau Hui Diong, Nor Shuhadah Mohd Yusoff, Maw Shin Sim, Raja Elina Raja Aziddin, Zamri Chik, Rusdi Abdul Rashid, Norliza Chemi, Zahurin Mohamed (2014). Quantitation of methadone and its metabolite in patients under maintenance treatment. JOURNAL OF ANALYTICAL TOXICOLOGY AUGUST 2014 Impact Factor: 2.63 DOI: 10.1093/jat/bku096
  102. Siti Norsyuhada Roffeei, Gavin P Reynolds, Nor Zuraida Zainal, Mas Ayu Said, Ahmad Hatim, Syarinaz Ahmad Aida, Zahurin Mohamed. Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.HUMAN PSYCHOPHARMACOLOGY CLINICAL AND EXPERIMENTAL 29(1):38-45 JANUARY 2014 Impact Factor: 1.85 DOI: 10.1002/hup.2366
  103. Siti Norsyuhada Roffeei, Gavin P. Reynolds, Nor Zuraida Zainal, Mas Ayu Said, Ahmad Hatim, Syarinaz Ahmad Aida & Zahurin Mohamed. 2014. Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone. Hum. Psychopharmacol Clin Exp 29: 38 45
  104. Siti Norsyuhada Roffeei, Zahurin Mohamed, Gavin P Reynolds, Mas Ayu Said, Ahmad Hatim, Elsa Haniffah Mejia Mohamed, Syarinaz Ahmad Aida, Nor Zuraida Zainal. Association of FTO, LEPR and MTHFR polymorphisms with metabolic syndrome in Malaysian schizophrenia patients receiving long- term antipsychotic treatment. Pharmacogenomics 2014; 15(4); 477-485(Tier 1; Impact Factor = 3.857).
  105. Sujatha Suthandiram, Gan Gin Gin, Shamsul Mohd Zain, Bee Ping Chong, Lian Lay Hoong, Chang Kian Meng, Ong Tee Chuan, Zahurin Mohamed. Genetic polymorphisms in the one-carbon metabolism pathway genes and susceptibility to non-Hodgkin lymphoma. TUMOR BIOLOGY NOVEMBER 2014 Impact Factor: 3.61 DOI: 10.1007/s13277-014-2785- 0
  106. Sujatha Suthandiram, Gan Gin Gin, Shamsul Mohd Zain, Batoul Sadat Haerian, Bee Ping Chong, Lian Lay Hoong, Chang Kian Meng, Ong Tee Chuan and Zahurin Mohamed. Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population. JOURNAL OF HUMAN GENETICS 59(5) MARCH 2014. Impact Factor: 2.53 DOI: 10.1038/jhg.2014.19
  107. Sujatha Suthandiram, Gan Gin Gin, Shamsul Mohd Zain, Bee Ping Chong, Lian Lay Hoong, Chang Kian Meng, Ong Tee Chuan and Zahurin Mohamed. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. PHARMACOGENOMICS 15(11):1479-1494 OCTOBER 2014 Impact Factor: 3.43 DOI: 10.2217/pgs.14.97 (Tier 1)
  108. Sujatha Suthandiram, Gin Gin Gan, Shamsul Mohd Zain Ping-Chong Bee, L.H. Lian, K.M. Chang, T.C. Ong, Zahurin Mohamed. Impact of genetic polymorphisms of MTHFR, SLC, and ABC on high-dose methotrexate toxicity and plasma levels in adults with haematological malignancies. EUROPEAN JOURNAL OF CANCER MAY 2014. Impact Factor: 4.82 DOI: 10.1016/j.ejca.2014.03.221
  109. Sujatha Suthandiram, Gin-Gin Gan, Shamsul Mohd Zain, Ping-Chong Bee, Lay-Hoong Lian,Kian-Meng Chang, Tee- Chuan Ong & Zahurin Mohamed1. Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics (2014) 15(11), 1479 1494 (Tier 1).
  110. Vijayapandi Pandy, Megala Narasingam, Thubasni Kunasegaran, Dharmani Devi Murugan and Zahurin Mohamed. Effect of Noni (Morinda citrifolia Linn.) fruit and its bioactive principles scopoletin and rutin on rat vas deferens contractility: An ex vivo study. The Scientific World Journal (2014). Impact Factor 1.730 (Tier 1)http://dx.doi.org/10.1155/2014/909586
  111. Yamunah Devi Apalasamy, Moy Foong Ming, Agus Salim, Sanjay Rampal, Awang Bulgiba, Zahurin Mohamed. Association of ADIPOQ gene with obesity and adiponectin levels in Malaysian Malays. Molecular Biology Reports (Impact Factor: 2.51). 01/2014; DOI:10.1007/s11033-014- 3147-0
  112. Yamunah Devi Apalasamy, Moy Foong Ming, Sanjay Rampal, Awang Bulgiba, Zahurin Mohamed. 2013. Genetic Association Study of INSIG2 rs7566605 polymorphism with obesity-related metabolic traits in Malaysian Malays.Genetic associations of the INSIG2 rs7566605 polymorphism with obesity-related metabolic traits in Malaysian Malays. GENETICS AND MOLECULAR RESEARCH: GMR 13(3):4904-4910 JULY 2014 Impact Factor: 0.85 DOI: 10.4238/2014.July.4.4
  113. Yamunah Devi Apalasamy, Moy Foong Ming, Sanjay Rampal, Awang Bulgiba, Zahurin Mohamed. 2013. Genetic Association Study of INSIG2 rs7566605 polymorphism with obesity-related metabolic traits in Malaysian Malays.Genetics and Molecular Research.Genet Mol Res 2014 Jul 4;13(3):4904-10. PMID:25062423.
  114. Yamunah Devi Apalasamy, Sanjay Rampal, Agus Salim, Moy Foong Ming, Awang Bulgiba, Zahurin Mohamed. 2014 .Association of ADIPOQ gene with obesity and adiponectin levels in Malaysian Malays. MOLECULAR BIOLOGY REPORTS 41(5) JANUARY 2014 Impact Factor: 1.96 DOI: 10.1007/s11033-014-3147-0
  115. Zain SM, Rosmawati M, Cooper D, Razali R, Rampal S, Mahadeva S, Chan WK, Anwar A, Nurul SMR, Anis SF, Cheah PL, Basu RC, Tan HL, Mohamed Z. Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non- alcoholic fatty liver disease. PLOS ONE 2014;9 (4):e95604 , PLOS ONE 9(4):E95604 APRIL 2014. Impact Factor: 3.53. DOI: 10.1371/journal.pone.0095604
  116. Apalasamy YD, Ming MF, Rampal S, Bulgiba A, Mohamed Z (2013).Association of Melanocortin-4 Receptor Gene Polymorphisms with Obesity-related Parameters in Malaysian Malays. Ann Hum Biol. Jan;40(1):102-6. (Tier 2; Impact Factor = 1.98)
  117. Batoul Sadat Haerian, Larry Baum, Patrick Kwan, Hui Jun Tan, Azman Ali Paymond, Zahurin Mohamed. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis. PHARMACOGENOMICS 14(10):1153-66 JULY 2013. Impact Factor: 3.43 DOI: 10.2217/pgs.13.104
  118. Baum, L., Haerian, BS ; Ng, HK ; Wong, V; Ng, PW ; Lui, CHT ; Sin, NC ; Zhang, C ; Tomlinson, B ; Wong, WKG ; Wong, KS ; Tan, HJ ; Raymond, AA ; Zahurin, M ; Kwan, P.VOLTAGE GATED SODIUM CHANNEL GENE POLYMORPHISMS ARE ASSOCIATED WITH EPILEPSY. Epilepsia 2013; 54(3);344-344 (Tier 1; Impact Factor = 3.909)
  119. Debbie Ann Loh, Foong Ming Moy, Nur Lisa Zaharan, Zahurin Mohamed. Eating Behaviour among Multi- Ethnic Adolescents in a Middle-Income Country as Measured by the Self-Reported Children s Eating Behaviour Questionnaire. PLOS ONE 8(12):E82885 DECEMBER 2013 Impact Factor: 3.53 DOI: 10.1371/journal.pone.0082885
  120. Fatemeh Hemmati, Leila Dargahi, Sanaz Nasoohi, Rana Omidbakhsh, Zahurin Mohamed, Zamrichik, Murali Naidu, Abolhassan Ahmadiani. Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine. BEHAVIOURAL BRAIN RESEARCH JUNE 2013 Impact Factor: 3.39 DOI: 10.1016/j.bbr.2013.06.016
  121. Ghasemi R, Dargahi L, Haeri A, Moosami L, Mohamed Z, Ahmadiani, A. Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders. MOLECULAR NEUROBIOLOGY 47(3) JANUARY 2013. Impact Factor: 5.29 DOI: 10.1007/s12035- 013- 8404-z
  122. Hwa Li Tan, Shamsul Mohd Zain, Rosmawati Mohamed, Sanjay Rampal, Kin-Fah Chin, Roma Choudhury Basu, Phaik Leng Cheah, Sanjiv Mahadeva, Zahurin Mohamed. Association of glucokinase regulatory gene polymorphisms with risk and severity of non- alcoholic fatty liver disease: an interaction study with adiponutrin gene. JOURNAL OF GASTROENTEROLOGY 49(6) JUNE 2013. Impact Factor: 4.02 DOI: 10.1007/s00535-013-0850-x
  123. Kavita S Subramaniam, Seng Tian Tham, Zahurin Mohamed, Yin Ling Woo, Mat Adenan Noor Azmi, Ivy Chung. Cancer- associated fibroblasts promote proliferation of endometrial cancer cells. Plos One (2013). July 2013. 8(7); e68923(Tier 1; Impact Factor = 3.53)
  124. Kavita S. Subramaniam, Seng Tian Tham, Zahurin Mohamed, Yin Ling Woo, Noor Azmi Mat Adenan, Ivy Chung. Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells. PLOS ONE 8(7):E68923 JULY 2013 . Impact Factor 3.534 DOI: 10.1371/journal.pone.0068923
  125. Larry Baum, Batoul Sadat Haerian, Ho-Keung Ng, Virginia CN Wong, Ping Wing Ng, Colin H.T.Lui, Ngai Chuen Sin, Chunbo Zhang, Brian Tomlinson, Gary Wing-Kin Wong, Hui Jan Tan, Azman Ali Raymond, Zahurin Mohamed and Patrick Kwan. Case control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy. HUMAN GENETICS 133(5):651-659 MAY 2014. Impact Factor: 4.52 DOI: 10.1007/s00439-013-1405-1
  126. Lay-Hoong Lian, Ai-Chin Loke, Nor Z Zainal, Zahurin Mohamed. Association study of the tryptophan hydroxylase 1 gene with major depressive disorder in three ethnic groups of the Malaysian population. Asian Biomedicine Vol. 7 No. 1 February 2013 (2013)DOI: 10.5372/1905- 7415.0701.xxx
  127. Lay-Hoong Lian, Ai-Chin Loke, Nor Z Zainal, Zahurin Mohamed. Association study of the tryptophan hydroxylase 1 gene with major depressive disorder in three ethnic groups of the Malaysian population. ASIAN BIOMEDICINE 7(1) FEBRUARY 2013 Impact Factor: 0.28 DOI: 10.5372/1905- 7415.0701.xxx
  128. Loke Ai Chin, Nor Zuraida Zainal, Lian AH, Zahurin Mohamed. 2013. Association study of the tryptophan hydroxylase 1 gene with major depressive disorder in three ethnic groups of the Malaysian population. Asian Biomedicine Journal 7(1): 105-112
  129. M.S.Sim, A.Hatim, G.P.Reynolds, Z.Mohamed. Association of a functional FAAH polymorphism with methamphetamine-induced symptoms and dependence in a Malaysian population.PHARMACOGENOMICS 14(5):505-14 APRIL 2013. Impact Factor: 3.43 DOI: 10.2217/pgs.13.25
  130. M.S.Sim, A.Hatim, G.P.Reynolds, Z.Mohamed. Association of a functional polymorphism in the FAAH gene with methamphetamine dependence and methamphetamine-induced symptoms in a Malaysian population. Pharmacogenomics (2013); 14(5):505-514 (Tier 1; Impact Factor = 3.97)04/2013; 14(5):505-14. DOI: 10.2217/pgs.13.25
  131. MOHD AIZAT ZAIN, Siti Norsyuhada Roffeei, Nor Zuraida Zainal, Sharmilla Kanagasundram, Zahurin Mohamed. Nonsynonymous polymorphisms of the PDLIM5 gene association with the occurrence of both bipolar disorder and schizophrenia. PSYCHIATRIC GENETICS 23(6) SEPTEMBER 2013. Impact Factor: 2.27 DOI: 10.1097/YPG.0000000000000015
  132. Megala Narasingam, Kamini Vijeepallam, Yasmin Khan, Zahurin Mohamed, Vijayapandi Pandy. Anxiolytic and antidepressant-like effects of Noni (Morinda Citrofilia L) fruits in mice. Indian Journal of Pharmacology 2013.Vol 45 (1). Neu/PP 83.
  133. Mohd Aizat Zain, Siti Norsyuhada Roffeei, Nor Zuraida Zainal, Sharmilla Kanagasundram, Zahurin Mohamed. Nonsynonymous polymorphisms of the PDLIM5 gene association with the occurrence of both bipolar disorder and schizophrenia. PSYCHIATRIC GENETICS 23(6) SEPTEMBER 2013. Impact Factor: 2.27 DOI: 10.1097/YPG.0000000000000015
  134. Nazree, Nur Elia; Loke, Ai Chin; Zainal, Nor Zuraida; Mohamed, Zahurin. Lack of Association between TPH2 gene polymorphisms with Major Depressive Disorder (MDD) in multiethnic Malaysian population.
  135. Nazree, Nur Elia; Loke, Ai Chin; Zainal, Nor Zuraida; Mohamed, Zahurin. Lack of Association between TPH2 gene polymorphisms with Major Depressive Disorder (MDD) in multiethnic Malaysian population. Asia Pacific Psychiatry 2013. (Tier 4; Impact Factor = 0.47)
  136. Ruziana Masiran, Hatta Sidi, Zahurin Mohamed, Suriati Mohamed Saini,Nik Ruzyanei NikJaafar. Association between 5HT2A polymorphism and selective serotonin re-uptake inhibitor (SSRI)-induced sexual desire disorder (SDD) among Malaysian women. ASIA- PACIFIC PSYCHIATRY 5 AUGUST 2013 Impact Factor: 0.42 DOI: 10.1111/appy.12043
  137. Shamsul Mohd Zain, Zahurin Mohamed, Sanjiv Mahadeva, Sanjay Rampal, Roma Choudhury Basu, Phaik Leng Cheah, Agus Salim, Rosmawati Mohamed. Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population. Plos One 2013; 8(3); 1-8. March 2013 | Volume 8 | Issue 3 | e58538(Tier 1; Impact Factor = 5.07)
  138. Shamsul Mohd Zain,*, Zahurin Mohamed,*, Sanjiv Mahadeva, Phaik-Leng Cheah, Sanjay Rampal, Kin-Fah Chin, Roma Choudhury Basu,** Hwa-Li Tan*, and Rosmawati Mohamed (2013). Impact of leptin receptor gene variants on risk of non-alcoholic fatty liver disease and its interaction with PNPLA3 variant. Journal of Gastroenterology and Hepatology 2013;28(5):873-9. doi: 10.1111/jgh.12104. (Tier 2; Impact Factor = 2.87)
  139. Soobitha Subenthiran, Noor Rain Abdullah, Joyce Pauline Joseph, Prem Kumar Muniandy, Mok Boon Teck, Kee Chee Cheong, Zakiah Ismail and Zahurin Mohamed (2013). Linkage Disequilibrium between Polymorphisms of ABCB1 and ABCC2 to Predict the Treatment Outcome of Malaysians with Complex Partial Seizures on Treatment with Carbamazepine Mono- Therapy at the Kuala Lumpur Hospital. PLOS ONE 8(5):E64827 MAY 2013 Kaohsiung Chang Gung Memorial Hospital, Taiwan Impact Factor: 3.53 DOI: 10.1371/journal.pone.0064827
  140. Soobitha Subenthiran, Noor Rain Abdullah, Prem Kumar Muniandy, Joyce Pauline Joseph, Kee Chee Cheong, Zakiah Ismail and Zahurin Mohamed. G2677T polymorphism can predict treatment outcome of Malaysians with complex partial seizures being treated with Carbamazepine. GENETICS AND MOLECULAR RESEARCH: GMR 12(4):5937-5944 NOVEMBER 2013 Impact Factor: 0.85 DOI: 10.4238/2013.November.26.3
  141. YD Apalasamy, A Bulgiba, YF Moy, Z Mohamed. Genetic Association Study of INSIG2 rs7566605 polymorphism with obesity-related metabolic traits in Malaysian Malays. Genetics and Molecular Research (2013).
  142. Zain SM, Mohamed Z, Mahadeva S, Cheah PL, Rampal S, Chin KF, Basu RC, Tan HL, Mohamed R. The impact of LEPR variants on risk of non-alcoholic fatty liver disease and its interaction with PNPLA3 variant. J Gastroenterol Hepatol ;28(5):873-9.
  143. Zain SM, Mohamed Z, Mahadeva S, Rampal S, Basu RC, Cheah PL, Agus S, Rosmawati Mohamed. Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non- alcoholic fatty liver disease in a multi- ethnic population. PLOS ONE 2013 Apr 8;8(4):e60729 (Tier 1 ISI-Cited Publication)
  144. Zain SM, Mohamed Z, Mahadeva S, Rampal S, Basu RC, Cheah PL, Salim A, Mohamed R. Susceptibility and Gene Interaction Study of the Angiotensin II Type 1 Receptor (AGTR1) Gene Polymorphisms with Non- Alcoholic Fatty Liver Disease in a Multi-Ethnic Population. PLOS ONE 8(3):E58538 MARCH 2013. Impact Factor: 3.53 DOI: 10.1371/journal.pone.0058538
  145. Apalasamy, Y.D., Ming, M.F., Rampal, S., Bulgiba, A., Mohamed, Z., 2012. Association of melanocortin-4 receptor gene polymorphisms with obesity-related parameters in Malaysian Malays. ANNALS OF HUMAN BIOLOGY 40(1) SEPTEMBER 2012. Impact Factor: 1.15 DOI: 10.3109/03014460.2012.720709
  146. Batoul Sadat Haerian, Larry Baum, Hui Jan Tan, Patrick Kwan, Azman Ali Raymond, Junji Saruwatari, Kazuko Nakagawa, Zahurin Mohamed. 2012. SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study.PHARMACOGENOMICS 13(13):1477-85 OCTOBER 2012. Impact Factor: 3.43 DOI: 10.2217/pgs.12.127
  147. Ghasemi R, Haeri A, Dargahi L, Mohamed Z, Ahmadiani A. 2012. Insulin in the Brain: Sources, Localization and Functions. MOLECULAR NEUROBIOLOGY 47(1) SEPTEMBER 2012. Impact Factor: 5.29 DOI: 10.1007/s12035-012- 8339-9
  148. Mohd Aizat Zain, Suffee Nusrat Jahan, Gavin P Reynolds, Nor Zuraida Zainal, Sharmilla Kanagasundram and Zahurin Mohamed 2012. Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration. BMC MEDICAL GENETICS 13(1):91 OCTOBER 2012 Impact Factor: 2.45 DOI: 10.1186/1471-2350-13-91
  149. Shamsul Mohd Zain, Rosmawati Mohamed, Sanjiv Mahadeva,Cheah Phaik Leng,Sanjay Rampal,Roma Choudhury Basu, Zahurin Mohamed. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease. HUMAN GENETICS 131(7):1145-52 JANUARY 2012. Impact Factor: 4.52 DOI: 10.1007/s00439-012- 1141-y
  150. Vijayapandi Pandy, Megala Narasingam and Zahurin Mohamed. Antipsychotic-like activity of Noni (Morinda citrifolia Linn.) in mice. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 12(1):186 OCTOBER 2012 Impact Factor: 1.88 DOI: 10.1186/1472-6882-12-186
  151. Y.D. Apalasamy, M.F. Ming, S. Rampal, A. Bulgiba and Z. Mohamed. 2012. Genetic association of SNPs in the FTO gene and predisposition to obesity in Malaysian Malays. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH. 45(12) AUGUST 2012. Impact Factor: 1.08 DOI: 10.1590/S0100-879X2012007500134
  152. Yamunah Devi Apalasamy, Moy Foong Ming, Sanjay Rampal,Awang Bulgiba, Zahurin Mohamed. 2012. Genetic association of SNPs in the FTO gene and predisposition to obesity in Malaysian Malays. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 45(12) AUGUST 2012, Impact Factor: 1.08 DOI: 10.1590/S0100-879X2012007500134
  153. BS Haerian, H Roslan, AA Raymond, CT Tan, KS Lim, SZ Zulkifli, EHM Mohamed, HJ Tan and Z Mohamed. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients. EPILEPTIC DISORDERS: INTERNATIONAL EPILEPSY JOURNAL WITH VIDEOTAPE 13(1):65-75 MARCH 2011.Impact Factor: 0.90 DOI: 10.1684/epd.2011.0419
  154. BS Haerian, H Roslan, AA Raymond, CT Tan, KS Lim, SZ Zulkifli, EHM Mohamed, HJ Tan and Z Mohamed. Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: A systematic review and meta-analysis. PHARMACOGENOMICS 12(5):713-25 MARCH 2011. Impact Factor: 3.43 DOI: 10.2217/pgs.10.212
  155. BS Haerian, H Roslan, AA Raymond, CT Tan, KS Lim, SZ Zulkifli, EHM Mohamed, HJ Tan and Z Mohamed. Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy. SEIZURE 20(5):387-94 FEBRUARY 2011. Impact Factor: 2.06 DOI: 10.1016/j.seizure.2011.01.008
  156. BS Haerian, KS Lim, EHM Mohamed, HJ Tan, CT Tan, AA Raymond, CP Wong, SW Wong, and Z Mohamed. Lack of association between synapsin II (SYN2) gene polymorphism and susceptibility epilepsy: A case- control study and meta-analysis. SYNAPSE 65(10):1073-9 OCTOBER 2011 Impact Factor: 2.43 DOI: 10.1002/syn.20939
  157. BS Haerian, KS Lim, EHM Mohamed, HJ Tan, CT Tan, AA Raymond, CP Wong, SW Wong, and Z Mohamed. Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy. SEIZURE 20(7):546-53 APRIL 2011. Impact Factor: 2.06 DOI: 10.1016/j.seizure.2011.04.003
  158. Ching-Lee Wan, Nor Zuraida Zainal, Lay-Hoong Lian, Zahurin Mohamed. Association of the functional polymorphism in the catechol-O-methyltransferase gene with schizophrenia in the three ethnic groups of the Malaysian population. PSYCHIATRY RESEARCH 189(1):67-71 MARCH 2011. Impact Factor: 2.68 DOI: 10.1016/j.psychres.2011.02.008
  159. EHM Mohamed, KS Tan, JM Ali, Z Mohamed. TT genotype of the methylenetetrahydrofolate reductase C677T polymorphism is an important determinant for homocysteine levels in multi-ethnic Malaysian ischaemic stroke patients. Annals Academy of Medicine. 2011. 40(4);186-191(Impact Factor = 1.01)
  160. Kong WM, Chik Z, Ramachandra M, Subramaniam U, Aziddin RER and Mohamed Z. Evaluation of the Effects of Mitragyna speciosa Alkaloid Extract on Cytochrome P450 Enzymes Using a High Throughput Assay. MOLECULES 16(9):7344-56 DECEMBER 2011 Impact Factor: 2.42 DOI: 10.3390/molecules16097344
  161. Mohamed EHM, Tan KS,Mohd Ali J, Mohamed Z.TT genotype of the methylenetetrahydrofolate reductase C677T polymorphism is an important determinant for homocysteine levels in multi-ethnic Malaysian ischaemic stroke patients.ANNALS OF THE ACADEMY OF MEDICINE, SINGAPORE 40(4):186-91 APRIL 2011 Department of Pharmacology, University of Malaya, Kuala Lumpur, Malaysia. Impact Factor: 1.22
  162. Mohamed, Z; Haerian, BS; Lim, KS; Tan, CT. Association of ABCB1 polymorphisms with response to sodium valproate in Malaysian epilepsy patients.Drug Metabolism Reviews 2011 May. 43:80-81
  163. Sim, MS; Sulaiman, AH; Jaafar, ANFA; Mohamed, Z. Association of SOD2 (superoxide dismutase 2) genetic polymorphisms with methamphetamine dependence in Malaysian population. Drug Metabolism Reviews 2011 May. 43:69-70
  164. Yamunah Devi Apalasamy, Moy Foong Ming, Sanjay Rampal, Awang Bulgiba and Zahurin Mohamed. Gender- Dependent Association of a 2-Adrenergic Gene Variant With Obesity Parameters in Malaysian Malays. ASIA- PACIFIC JOURNAL OF PUBLIC HEALTH 27(2) DECEMBER 2011. Impact Factor: 1.11 DOI: 10.1177/1010539511430250
  165. Zahurin Mohamed, Zuraida Zainal, Lay Hoong Lian and Ai Chin Loke. Association Study of Tryptophan Hydroxylase 2 and Serotonin Transporter Genes with Major Depressive Disorder in Malaysian Ethnic Subgroups. Clinical Psychopharmacology and Neuroscience 2011;9 (1):40-40.
  166. Zain, MAM; Zainal, NZ; Kanagasundram, S; Mohamed, Z Association between PDLIM5 gene and bipolar disorder in Malaysian population. Drug Metabolism Reviews 2011 May. 43:57-57
  167. Zain, SM; Mohamed, Z; Mahadeva, S; ; Cheah, PL ; Rampal, S ; Basu, RC ; Mohamed, R. Does polymorphism in patatin-like phospholipase 3 gene (PNPLA3) confer risk of nonalcoholic fatty liver disease (NAFLD) in multiethnic Malaysian population? Drug Metabolism Reviews Volume: 43 Pages: 56-57 Published: MAY 2011
  168. BS Haerian, H Roslan, AA Raymond, CT Tan, KS Lim, SZ Zulkifli, EHM Mohamed, HJ Tan and Z Mohamed. 2010. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: A systematic review and meta-analysis. SEIZURE 19(6):339-46 JULY 2010 , Impact Factor: 2.06 DOI: 10.1016/j.seizure.2010.05.004
  169. Chik Z, Basu RC, Pendek R, Lee TC and Mohamed Z. 2010. A Bioequivalence Comparison of Two Formulations of Rifampicin (300-vs 150-mg Capsules): An Open-Label, Randomized, Two-Treatment, Two-Way Crossover Study in Healthy Volunteers. CLINICAL THERAPEUTICS 32(10):1822-31 SEPTEMBER 2010 Impact Factor: 2.59 DOI: 10.1016/j.clinthera.2010.09.006
  170. M.S. SIM, A. HATIM, V.L. RAJ, M.H. HABIL AND Z. MOHAMED. 2010. Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population. BRAIN RESEARCH 1357:91-6 OCTOBER 2010 Impact Factor: 2.83 DOI: 10.1016/j.brainres.2010.08.053
  171. Z Chik, AM Mustafa, TC Lee and Z Mohamed. Analysis of Captopril in Human Plasma Using Gas Chromatography- Mass Spectrometry (GCMS) with Solid-Phase Extraction (SPE). CURRENT ANALYTICAL CHEMISTRY 6(4):329-333 OCTOBER 2010. Impact Factor: 1.19
  172. Haerian, BS, Mohamed Z, Mohamed EHM, Lim KS, Tan HJ, Tan CT, Raymond AA. Role of ABCB1 C3435T variant in response to antiepileptic drugs in epilepsy: A review. Med & Health 2009; 4(2): 64-74
  173. Z.Chik, R.C. Basu, R. Pendek, T.C. Lee, Z. Mohamed. Comparative bioavailability study of two salbutamol tablets in healthy adult volunteers.INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 47(6):413-8 JULY 2009. Impact Factor: 1.04 DOI: 10.5414/CPP47413
  174. Zamri Chik, Z.Mohamed and TC Lee. Comparative bioavailability study of two salbutamol tablets in healthy adult volunteers. Int J Clin Pharmacol Ther (2009) 47(6):413-418 (Tier 4; Impact Factor = 1.38)
  175. A.M. Mustafa, N.T. Malintan, S.Seelan, Z.Zhan, Z.Mohamed, J.Hassan, R.Pendek, R.Hussain, N.Ito, Phytestrogens levels determination in the cord blood from Malaysia rural and urban populations. TOXICOLOGY AND APPLIED PHARMACOLOGY 222(1):25-32 AUGUST 2007 Impact Factor: 3.63 DOI: 10.1016/j.taap.2007.03.014
  176. Eng HS, Mohamed Z, Calne R, Lang CC, Mustafa AM, Seet WT and Tan SY, The influence of CYP3A gene polymorphisms on cyclosporine dose requirement in renal allograft recipients. KIDNEY INTERNATIONAL 69(10):1858-64 MAY 2006. Impact Factor: 8.52 DOI: 10.1038/sj.ki.5000325
  177. Mohamed, EHM; Tan, KS; Mohamed, Z, et al 2006. Angiotensin-converting enzyme deletion (ACE D) polymorphism and ischaemic stroke in multi-ethnic Malaysian population. ACTA PHARMACOLOGICA SINICA 27:232-232 JULY 2006. Impact Factor: 2.50
  178. Z.Mohamed. Understanding Bioequivalence: Study Concept and Design. Bulletin of Clinical Research. 2006;2(1):6- 9.
  179. Antiinflammatory Properties of Mitragyna Speciosa Extract. R.E.R. Aziddin, MR Mustafa, Z.Mohamed and MA Mohd. Malaysian Journal of Science 2005;24:191-194,
  180. Pang, YS, Wong LP, Lee TC, Mustafa AM, Mohamed, Z & Lang CC. 2004. Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects. Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 58(3):332-5 SEPTEMBER 2004. Impact Factor: 3.69 DOI: 10.1111/j.1365-2125.2004.02144.x
  181. YS Pang, Wong LP TC Lee, Z Mohamed, Chim C Lang , Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 58(6):680-680 DECEMBER 2004 Impact Factor: 3.69 DOI: 10.1111/j1365- 2125.2004.02271
  182. CC Lang, SK Jamal, Z.Mohamed, MR Mustafa, AM Mustafa, and TC Lee , Evidence of an interaction between nifedipine and nafcillin in humans.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 55(6):588-90 JUNE 2003 Impact Factor: 3.69 DOI: 10.1046/j.1365- 2125.2003.01789.x
  183. H.A. El-Sheikh, B.H. Ali, M Zahurin, A.M. Mustafa, G. Alhadrami and A.K. Bashir , Comparative Pharmacokinetics of Theophylline in Camels (Camelus dromedarius) and Goats (Caprus hircus). JOURNAL OF VETERINARY MEDICINE SERIES A 48(10):581-6 JANUARY 2002. Impact Factor: 0.93 DOI: 10.1046/j.1439- 0442.2001.00401.x
  184. Lucy Chan, SM Sim, O Farizaturradiah, Z.Mohamed , "Clinical pharmacokinetics of low dose sufentanil in surgical patients", Asean Journal of Anasethesiology 2001, Vol. 22, pg. 99-102,
  185. Lang, C.C., Mustafa A.M., Jamal, S.K., Mohamed, Z. et al 1998. Nafcillin is a potent inducer of cytochrome P4503A activity in humans. Naunyn-Scmiedebergs Archives of Pharmacology. 358 (1): R458-R458
  186. Effect of gestational age on gentamicin pharmacokinetic parameters in the newborn. O.Farizaturradiah, Z.Mohamed, S.M.Sim and C.T.Lim , Journal of the University of Malaya Medical Centre 1997;2 (1):35-38
  187. High performance liquid chromatography of dextromethorphan and its main metabolite in human urine. Y.H.Noraliza, Z.Mohamed, A.Zaini, C.C.Lang, , Journal Of the University of Malaya Medical Centre 1997;2 (1):23-26,
  188. Yong. BH, Sim, Ong.G and Mohamed, Z., "Plasma bupivacaine concentrations following axillary block - A study in Malaysian patients", Asia Pacific Journal of Pharmacology.1995, Vol. 10, pg. 45-48,
  189. W. Tassaneeyakul, Z.Mohamed, D.J. Birkett, M.E.McManus, M.E. Veronese, R.H. Tukey, L.C.Quattrochi, F.J.Gonzalez and J.O.Miners , "Caffeine as a probe for human cytochrome P450: Validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques.", 1992, Pharmacogenetics and Genomics, Vol. 2, pg. 173 - 183) (Impact Factor = 3.991) (Number of citations = 95). Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques. PHARMACOGENETICS AND GENOMICS 2(4) AUGUST 1992 Impact Factor: 3.45
  190. Z.Mohamed. In vitro metabolism of caffeine by rabbit and rat liver microsomes. Proceedings of the Malaysian Biochemical Society Conference (1991). Vol 16, pg 93-99
  191. Birkett, DJ, Mohamed Z and Miners, JO. Urine caffeine concentrations to control caffeine intake during competitive sports events. EUROPEAN JOURNAL OF PHARMACOLOGY 183(2):633-633 JULY 1990 Impact Factor: 2.68 DOI: 10.1016/0014- 2999(90)93558-8
  192. Mustafa Ali Mohd, Z.Mohamed and Muhamad Zakaria. Studies on the phytochemical and pharmacological properties of the Dioscorea species. Proceedings of the Malysian Biochemical Society Conference (1986), Vol 12, pg 165-169
  193. Z.Mohamed, I.H. Stevenson. Studies on the disposition and metabolism of 8-methoxypsoralen in experimental animals. Proceedings ofthe Malaysian Biochemical Society Conference. Vol 12, pg 87-92
Books
  1. Malaysian Guidelines to Good Clinical Practice. Third Edition. Published by the Ministry of Health, Malaysia. January 2011.
  2. Mustafa Ali Mohd and Zahurin Mohamed "Sample Preparation for GCMS Analysis of Biomedical Samples. Xenobiotic Analysis Series Vol 7. ", 2003, ISBN No. 983-2085-50-0,
  3. Sample Preparation for GCMS Analysis of Biomedical Samples. Xenobiotic Analysis Series Vol 7. Mustafa Ali Mohd and Zahurin Mohamed. 2003. ISBN No. 983-2085-50- 0
  4. Basics of column and solvent selection in HPLC Analysis. Xenobiotic Analysis Series Vol 5. Mustafa Ali Mohd and Z Mohamed. 2001. Penerbitan Salafi,
  5. Drugs of Abuse. Xenobiotic Analysis Series Vol 4. Mustafa Ali Mohd, Hussain Habil and Z.Mohamed. 2001, University of Malaya Press.
  6. Semi Micro HPLC and LCMS. Xenobiotic Analysis Series Vol 6. Mustafa Ali Mohd and Z. Mohamed. 2001. Penerbitan Salafi.
  7. Troubleshooting HPLC Systems. Xenobiotic Analysis Series Vol 2. Mustafa Ali Mohd and Z. Mohamed. 2001, Penerbitan Salafi.
  8. Abdul Rani Abdullah, Kulenthran Arumugam, Melissa Chan, Mustafa Ali Mohd, Rokiah Pendek, Ruby Hussain, Samsinah Hussain & Z.Mohamed. "Endocrine-Disrupting Chemicals. Xenobiotic Analysis Series Vol 3. ", 2000, SUCXeS
  9. Lee Toong Chow, Yuen Kah Hay, Yahaya Hassan, Fudziah Dato Ariffin, Zahurin Bt Mohamed, Aishah Latiff, Aishah Adam "Ministry of Healths "Malaysian Guidelines for the Conduct of Bioavailability and Bioequivalence Studies", 2000,
  10. Mustafa Ali Mohd, Hussain Habil and Z.Mohamed. Drugs of Abuse. Xenobiotic Analysis Series Vol 2. 2000.
  11. Mustafa Ali Mohd, Yuki Hashi and Z.Mohamed. Volatile Organic Compounds. Xenobiotic Analysis Series Vol 1. 1999
  12. Ramli Abd Ghani, Zahurin Bt Mohamed, Nazrin Ahmad Azli, Ho Tze Ming and Faridah Aryani Md Yusoff "Ministry of Healths "Guidelines for Application to Conduct Drug-Related Clinical Trials in Malaysia", 1999,
  13. REVIEW OF MEDICAL PHYSIOLOGY by W.F.Ganong. (KAJIAN SEMULA FISIOLOGI PERUBATAN). Translated by Mustafa Ali Mohd, Zurina Ismail & Zahurin Mohamed. Awarded second price for best translated science book for 1996. 1994 (Translation published by Dewan Bahasa dan Pustaka). Dewan Bahasa dan Pustaka. ,
  14. FUNDAMENTALS OF FIXED PROSTODONTICS by H.T. Shillingburg, S.Hobo & L.D. Whitsett. (ASAS PROSTODONTIKS TETAP). Translated by Mustafa Ali mohd, Noor Hayaty Kassim & Zahurin Mohamed. 1991 (Translation published by Dewan Bahasa dan Pustaka)
  15. LIVING NUTRITION (PEMAKANAN UNTUK HIDUP) by F.J. Store & M. McWilliams. Translated by Mustafa Ali Mohd, Zahurin Mohamed. Zurina Ismail & Tika Haji Mohamed. 1990, John Wiley & Sons (Translation published by Dewan Bahasa dan Pustaka,
  16. BASIC MICROBIOLOGY WITH APPLICATIONS by T.D.Brock, K.M.Brock and D.M.Ward. Published by (ASAS MIKROBIOLOGI DAN PENGGUNANNYA)Translated by Zahurin Mohamed, Mustafa Ali Mohd, Tik Haji Mohamed & Zurina Ismail. 1989, Prentice-Hall, New Jersey (Translation published by Dewan Bahasa dan Pustaka)
Article in Proceeding
  1. High performance liquid chromatography of dextromethorphan and its main metabolite in human urine.Y.H.Noraliza, Z.Mohamed, A.Zaini, C.C.Lang. Journal Of the University of Malaya Medical Centre 1997;2(1):23-26,
  2. In vitro metabolism of caffeine by rabbit and rat liver microsomes. Z.Mohamed. Proceeding of the Malaysian Biochemical Society Conference 1991; 16: 93- 99.
  3. Studies on the disposition and metabolism of 8- methoxypsoralen in experimental animals. Proceedings of the Malaysian Biochemical Society Conference 1986;12:87-92,
  4. Studies on the disposition and metabolism of 8- methoxypsoralen in experimental animals. Z Mohamed and IHStevenson. Proceedings of the Malaysian Biochemical Society Conference 1986; 12:87-92,
  5. Studies on the phytochemical and pharmacological properties of the Dioscorea species. Mustafa Ali Mohd, Z. Mohamed and Muhamad Zakaria. Proceedings of the Malaysian Biochemical Society Conference 1986; 12: 165 - 169
Other Publications
  1. Berita Minggu. Column Sihat. Ahad , 5 Jun 2011. Muka Surat 6. "Kaitan gen dan ubat. Projek Variasi Manusia kenal pasti rawatan, bersesuaian DNA pilih penyakit". - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  2. Making Drugs affordable. Interview with Zahurin Mohamed. Malaysian Business. A Special Focus on Academic Value Creation. August 2010. Page 7. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  3. Pil Perangsang IQ. Berita Harian. Interview with Zahurin Mohamed. Tuesday 30th November 2010 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  4. Zahurin Mohamed. 2010. Ubat Generik vs Ubat Berjenama. iSihat. Ogos 2010. 48-49. - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  5. Zahurin Mohamed. 2010. Ubat Generik: Apa yang anda perlu tahu. iSihat. Julai 2010. 48-49 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)
  6. Zahurin Mohamed. Ubat Generik: Cara Menguji Keberkesanan dan Tahap Keselamatan. iSihat. September 2010; 46-47 - Mass Media(Newspaper,Radio,Tv,Popular Magazine)

RESEARCH INTEREST

  • Clinical Pharmacokinetics
  • Pharmacogenomics
  • Genetic Polymorphism of the drug-metabolizing enzymes
  • Endocrine Disrupting Compounds (EDCs) in the Environment

RESEARCH PROJECT

National
  1. 2014 - 2017, HTMC Flagship project
    PARTNER for a low income urban community. Principal Investigator. 2012 -2014 (HTMC flagship project). FL 009 -2011, RM 971,000 ( Consultant)
  2. 2011 - 2016, High Impact Research (HIR)
    Beijing Genomic Institute: Project on Obesity ( Principal Investigator(PI))
  3. 2014 - 2014, Geran Penyelidikan Universiti Malaya (UMRG)
    The role of various Genetic Polymorphisms in Childhood Obesity ( Consultant)
  4. 2014 - 2014, High Impact Research (HIR)
    Pharmacogenomics Studies (2013) ( Principal Investigator(PI))
  5. 2014 - 2014, High Impact Research (HIR)
    Obesity in Malaysian adolescent population: Prevalence, risk factors, complications and intervention ( Consultant)
  6. 2014 - 2014, University of Malaya
    Setting up of the University of Malaya Bioequivalence and Testing Centre (UBAT) ( Principal Investigator(PI))
  7. 2010 - 2013, Geran Penyelidikan Universiti Malaya (UMRG)
    Pharmacogenomics of Metabolic Syndrome in Schizophrenia ( Consultant)
  8. 2012 - 2012, High Impact Research (HIR)
    Pharmacogenomics Studies ( Principal Investigator(PI))
  9. 2011 - 2011, High Impact Research (HIR)
    Pharmacogenomic Studies ( Principal Investigator(PI))
  10. 2008 - 2010, Short Term Research Fund (Vote F)(PJP)
    Salivary compared to systemic measurement in the pharmacokinetic assessment of testosterone transdermal delivery system for the hormone replacement therapy. ( Consultant)
  11. 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG)
    Association of Selected Candidate Genes With Response To Antiepileptic Drugs ( Principal Investigator(PI))
  12. 2009 - 2010, Fundamental Research Grant Scheme (FRGS)
    Variation Across candidate genes and its role in the development of non-alcoholic fatty liver disease (NAFLD) and its complications in patients with metabolic syndrome ( Consultant)
  13. 2009 - 2010, Geran Penyelidikan Universiti Malaya (UMRG)
    Case-control Study in determining the risk factors for the occurrence of pre-term birth in the Malaysian Population ( Consultant)
  14. 2010, Geran Penyelidikan Universiti Malaya (UMRG)
    Association of Genetic Polymorphisms in selected candidate genes with response to atorvastatin therapy. Imran Zainal Abidin.RM70,000. ( Coordinator)
  15. 2008 - 2009, Geran Penyelidikan Universiti Malaya (UMRG)
    Pharmacogenomics of Major Depressive Disorder ( Principal Investigator(PI))
  16. 2009, Geran Penyelidikan Universiti Malaya (UMRG)
    Pharmacogenomic Study on Bipolar Disorders: A Case-Control Study. Gene Analysis Study of Selected Candidate Genes and Regulation of Gene Expression in Bipolar Disorder Patient on Response to Quetiapine Medication. Sharmilla A/P Kanagasundram. RM60,000 ( Consultant)
  17. 2007 - 2008, Geran Penyelidikan Universiti Malaya (UMRG)
    Polymorphism of various genes in schizophrenia ( Principal Investigator(PI))
International
  1. 2015 - 2016, National Institute of Health, USA
    GENOMIC MEDICINE IMPLEMENTATION : THE PERSONALIZED MEDICINE ( Principal Investigator(PI))
  2. 2009 - 2010, UNESCO Biennial Partcipation Programme
    SITUATIONAL ANALYSIS OF BIOETHICS AWARENESS AND EDUCATION in the face of the biosciences revolution: Towards resource building and policy frameworks in support of ethical practice in Science, Technology and Healthcare in Malaysia. ( Consultant)
University
  1. 1998 - 2000, MOSTI
    Comparison of the pharmacokinetics of subcutaneous tramadol between elderly and young patients following surgery ( Consultant)
  2. 1998 - 2000, MOSTI
    Pharmacokinetics of subcutaneously admiminstered morphine - a comparative study between elderly and young patients ( Consultant)

CONSULTANCY PROJECT

  • An Open Labelled Study of Clopidogrel, Pharmaniaga/Infokinetics
    01 Jan 2013 - 01 Jan 2013 (National)
  • An Open Label, Randomized, Two Period, Two Sequences, Crossover, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Captopril, Namely, (Apo Capto) [Reference Compound] 25mg Tablet Vs. Caporil 25mg Tablet [Test Compounds] in Healthy Adult Human Subjects Under Fasting Conditions, IMEKS Pharma Sdn Bhd
    01 Jan 2013 - 01 Jan 2013 (National)
  • Bioequivalence Studies for 6 Different Products of Idaman Pharma Manufacturing Sdn Bhd (Amounting to >Rm1,000,000 Over a Period of Two Years., Idaman Pharma Manufacturing Sdn Bhd
    01 Dec 2010 - 01 Dec 2012 (National)
  • An Open Label, Randomized, Two Period, Two Sequence, Crossover, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Acyclovir 200mg Dispersible Tablets in Healthy Adult Human Subjects Under Fasting Conditions, Idaman Pharma Sdn Bhd
    01 Jan 2012 - 01 Jan 2012 (National)
  • An Open Label, Randomized, Two Period, Two Sequence, Crossover, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Diazepam 5mg Tablets in Healthy Adult Human Subjects Under Fasting Conditions.Protocol No:UM-003-11, Idaman Pharma Sdn Bhd
    01 Jan 2012 - 01 Jan 2012 (National)
  • An Open Label, Randomized, Two Period, Two Sequence, Crossover, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Tetracycline Tablets in Healthy Adult Human Subjects Under Non Fasting Conditions, Idaman Pharma Sdn Bhd
    01 Jan 2011 - 01 Jan 2011 (National)
  • An Open Label, Randomized, Two Period, Two Sequence, Crossover, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Ampicillin Tablets in Healthy Adult Human Subjects Under Non Fasting Conditions, Idaman Pharma Sdn Bhd
    01 Jan 2011 - 01 Jan 2011 (National)
  • The Comparative Bioequivalence Study of Three Formulations of Cloxacillin (Isoxacilla 250 Mg (Test), Isoxacilla 250 Mg (Test) and Monoclox 250 Mg (Reference) Capsules) in Healthy Adult Human Subjects Under Fasting Conditions, Idaman Pharma Sdn Bhd
    01 Jan 2011 - 01 Jan 2011 (National)
  • The Comparative Bioequivalence Study of Two Formulations of Amoxycillin (Synamox 250 Mg and Amoxicillin 250 Mg Capsules) in Healthy Adult Human Subjects Under Fasting Conditions, Idaman Pharma Sdn Bhd
    01 Jan 2011 - 01 Jan 2011 (National)
  • An Open Label, Randomized, Three Period, Six Sequence, Crossover, Comparative Evaluation of Relative Bioavailabilities of Three Formulations of Penicillin V 250mg Tablet in Healthy Adult Human Subjects Under Fasting Conditions, Idaman Pharma Manufacturing Sdn Bhd
    01 Dec 2010 - 01 Dec 2010 (National)
  • An Open Label, Randomized, Two Period, Two Sequence, Crossover, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Naproxen 550mg Tablets in Healthy Adult Human Subjects Under Fasting Conditions, Dynapharm (M) Sdn. Bhd.
    01 Dec 2010 - 01 Dec 2010 (National)
  • An Open-Label, Randomised, Two-Periods, Two Sequences, Cross-Over, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Naproxen in Healthy Adult Human Subjects Under Fasting Conditions, Dynapharm
    01 Dec 2009 - 01 Dec 2010 (National)
  • An Open-Label, Randomised, Two-Periods, Two Sequences, Cross-Over, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Ketoconazole 200mg in Healthy Adult Human Subjects Under Fasting Conditions, SM Pharmaceuticals Sdn Bhd
    01 Dec 2008 - 01 Dec 2008 (National)
  • An Open-Label, Randomised, Two-Periods, Two Sequences, Cross-Over, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Cetrizine in Healthy Adult Human Subjects Under Fasting Conditions, SM Pharmaceutical Sdn Bhd
    01 Dec 2008 - 01 Dec 2008 (National)
  • An Open-Label, Randomised, Two-Periods, Two Sequences, Cross-Over, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Ibuprofen in Healthy Adult Human Subjects Under Fasting Conditions, SM Pharmaceuticals Sdn Bhd
    01 Dec 2008 - 01 Dec 2008 (National)
  • An Open-Label, Randomised, Two-Period, Two Sequence, Crossover, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Doxycycline in Healthy Adult Male Subjects Under Fasting Conditions, Innovax
    01 Dec 2007 - 01 Dec 2007 (National)
  • An Open-Label, Randomised, Two-Periods, Two Sequences, Cross-Over, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Glibenclamide 5 Mg in Healthy Adult Human Subjects Under Fasting Conditions, Idaman Pharma Manufacturing Sdn Bhd
    01 Dec 2007 - 01 Dec 2007 (National)
  • An Open-Label, Randomised, Two-Periods, Two Sequences, Cross-Over, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Salbutmol in Healthy Adult Human Subjects Under Fasting Conditions, Idaman Pharma manufacturing Sdn Bhd
    01 Dec 2007 - 01 Dec 2007 (National)
  • An Open-Label, Randomised, Two-Period, Two Sequence, Crossover, Comparative Evaluation of Relative Bioavailabilities of Two Formulations of Doxycycline in Healthy Adult Male Subjects Under Fasting Conditions, Innovax Sdn Bhd
    01 Dec 2007 - 01 Dec 2007 (National)
  • The Comparative Bioequivalence Study of a Generic (Covastin from Xepa Soul Pattinson) and The Proprietary (Zocor from Msd) 40 Mg Simvastatin in Healthy Human Volunteers., Xepa Soul Pattinson
    01 Dec 2001 - 01 Dec 2001 (National)
  • The Comparative Bioequivalence Study of a Generic (Vascor from Upha) and The Proprietary (Zocor from Msd) 40 Mg Simvastatin in Healthy Human Volunteers., Upha
    01 Dec 2001 - 01 Dec 2001 (National)
  • The Comparative Bioequivalence Study of a Generic (Raza Enalapril from Raza Manufacturing) and The Proprietary Renitec from Msd) 20 Mg Enalapril in Healthy Human Volunteers., RAZA Manufacturing Sdn Bhd
    01 Dec 2001 - 01 Dec 2001 (National)
  • Bioequivalence Study: The Comparative Bioequivalence Study of Generic (Capriten from Xepa-Soul Pattinson) and The Proprietary (Capoten from Bms) 25 Mg Captopril Tablet in Healthy Human Volunteers., Xepa-Soul Pattinson
    01 Dec 2000 - 01 Dec 2000 (National)
  • Bioequivalence Study: The Comparative Bioequivalence Study of Generic (Captopril Denk from Luen Wah Medical Company) and The Proprietary (Capoten from Bms) 25 Mg Captopril Tablet in Healthy Human Volunteers, Luen Wah Medical Company
    01 Dec 1999 - 01 Dec 2000 (National)
  • The Comparative Bioequivalence Study of Generic (Kimafen from Duopharma) and The Proprietary (Capoten from Bms) 25 Mg Captopril Tablet in Healthy Human Volunteers, Duopharma
    01 Jan 2000 - 01 Jan 2000 (National)
  • Phase III Trial of Rsd921 as a Local Anaesthetic. The Studies Were a Series of 3 Studies: (a) The Local Anaesthetic Effect of Rsd921 On Healthy Volunteers (B) The Dermal Reactions Against Rsd921 in Healthy Volunteers (C) Clinical Evaluation of Rsd921 as a Local Anesthetic in Patients, CCM Pharma
    01 Dec 1998 - 01 Dec 1999 (National)
  • Bioequivalence Study: The Comparative Bioequivalence Study of Generic Omeprazole(Romesec from Ranbaxy) and The Proprietary (Losec from Astra) 25 Mg Omeprazole Capsule in Healthy Human Volunteers., Ranbaxy
    01 Dec 1999 - 01 Dec 1999 (International)
  • The Bioequivalence of Generic Methyldopa (Produced by Raza) and The Proprietary Methyldopa (Aldomet, Produced by Merck , Sharp & Dohme) in Healthy Volunteers. Raza Manufacturing Sdn Bhd 02/06/1997-31/12/1998, RAZA Manufacturing Sdn Bhd
    01 Dec 1998 - 01 Dec 1998 (National)
  • Bioequivalence Study:The Bioequivalence of Generic Isosorbide-5-Mononitrate Controlled-Release Form (Isotain 60 Mg Cr Tablet from Ccm Pharma Sdn. Bhd) and The Proprietary Isosorbide-5-Mononitrate (Imdur 60 Mg from Astra) in Healthy Volunteers, CCM PHARMA
    01 Dec 1998 - 01 Dec 1998 (International)
  • Analysis of Contents in a Chinese Cough Medication for The Possible Presence of Opioids., Veloo, Guna & Ramani Advocates and Solicirors, Singapore
    01 Dec 1998 - 01 Dec 1998 (International)
  • Bioequivalence Study:The Bioequivalence of Generic Methyldopa (Produced by Raza) and The Proprietary Methyldopa (Aldomet, Produced by Merck , Sharp & Dohme) in Healthy Volunteers., RAZA MANUFACTURING SDN BHD
    01 Dec 1997 - 01 Dec 1998 (International)
  • Bioequivalence Study of Generic Atenolol to The Proprietary Atenolol. My Role Was to Develop and Validate The Assay Method, Recruit The Subjects and Produced a Report., Norse Crown Pharmaceuticals
    01 Dec 1997 - 01 Dec 1997 (International)
  • Acute Toxicity Test On Rubber Gloves. My Role is to Monitor The Effects On Animals, Baxter Health Care SA
    01 Dec 1995 - 01 Dec 1995 (International)

PAPER PRESENTED

PLENARY SPEAKER
  1. Integration of Health & Technology for Human Well-Being & Ecosystem, International Symposium on Allied Health Sciences, Universiti Sains Malaysia (International) (05 Sep 2015 - 06 Sep 2015)
  2. Pharmacogenomics Studies in a Multiethnic Population, Pharmacology and Physiology Scientific Congress, Malaysian Society of Pharmacology and Physiology (International) (22 Aug 2014 - 24 Aug 2014)
  3. Bioethics and Society, Launching of the National Bioethics Council and Presentaion of the Letter of Appointment by the Minister of Science, Technology and Innovation, YB Datuk Seri Panglima Dr Maximus Johnity Ongkili, Ministry of Science, Technology and Innovation (National) (22 May 2012 - 23 May 2012)
  4. The Pharmacogenomics Approach to Personalised Medicine, Clinical Research and Trials Excellence Congress, Clinical Research Centre, Ministry of Health, Malaysia (National) (21 Oct 2008 - 23 Oct 2008)
  5. Pharmacogenomics and the Promise of Personalised Medicine, 33rd Annual Conference of the Malaysian Society for Biochemistry and Molecular Biology, Malaysian Society for Biochemistry and Molecular Biology (National) (27 Aug 2008 - 28 Aug 2008)
  6. Bioequivalence studies: The process and its current status in Malaysia. Z.Mohamed. , 16th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology. 25th-26th June 2001, Malaysian Society of Pharmacology and Physiology (National) (25 Jun 2001 - 26 Jun 2001)
INVITED SEMINAR
  1. Pharmacogenomics, International Medical University Celebration of Research , International Medical University (University) (01 May 2008 - 02 May 2008)
INVITED SPEAKER
  1. Challenges of Postgraduate Studies, 29th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology (MSPP), Malaysian Society of Pharmacology and Physiology (National) (24 Aug 2015 - 25 Aug 2015)
  2. National Bioethics Council Role in Promoting Ethics in Research Excellence , National Symposium on Ethical Issues in Research II. , Universiti Teknologi Mara (National) (19 May 2015 - 19 May 2015)
  3. Informed Consent. Exercises on Informed Consent., Good Clinical Practice Workshop. 17-19 March 2015, Clinical Investigation Centre, University of Malaya (National) (17 Mar 2015 - 19 Mar 2015)
  4. The Role of Genetic Polymorphisms of Drug Targets and Transporter Genes in Responsiveness to Antiepileptic Drugs, Golden Helix Symposia 2015: Next Generation Pharmacogenomics, Golden Helix Foundation and University of Malaya (International) (11 Mar 2015 - 12 Mar 2015)
  5. Use of Health Economics in Personalised Medicine, Monash Health Economics Forum 2014 "Value of Medicines: Patient's and Healthcare Professional's Perpectives", The School of Pharmacy, Monash University Malaysia (National) (29 Oct 2014 - 30 Oct 2014)
  6. (1) Ethical Review (2) Informed Consent Process (3) Scenarios of Issues in Informed Consent, Good Clinical Practice Workshop 12-14 August 2014, Clinical Investigation Centre (National) (12 Aug 2014 - 14 Aug 2014)
  7. Association of candidate gene polymorphisms with reduction in body mass index following antipsychotic switching to aripiprazole or ziprasidone, 3rd SEAPHARM Meeting and International Seminar and Workshop on Molecular Medicine: From Basic Science to Clinical Care, University of Yarsai, RIKEN, The University of Tokyo and Thailand Centre of Excellence in Life Sciences (International) (15 Apr 2014 - 16 Apr 2014)
  8. (1) Informed Consent Process (2) Scenarios of Issues in Informed Consent, Good Clinical Practice Workshop 8-10 April 2014, Clinical Investigation Centre (National) (08 Apr 2014 - 10 Apr 2014)
  9. (1) Informed Consent Process (2) Exercises on Informed Consent, Workshop on Good Clinical Practice Dec 2013, Clinical Investigation Centre (National) (10 Dec 2013 - 12 Dec 2013)
  10. (1) Institutional Review Board (2) Informed Consent Process (3) Exercises on Informed Consent, Good Clinical Practice Workshop, Clinical Investigation Centre, UMMC (National) (12 Nov 2013 - 14 Nov 2013)
  11. Etika Penggunaan Haiwan Dalam Kajian & Penyelidikan, Kolokium Kebajikan dan Kesejahteraan Haiwan mengikut Perspektif Islam. , Kementerian Pertanian dan Industri Asas Tani (National) (02 Jul 2013 - 02 Jul 2013)
  12. THE ASSOCIATION BETWEEN -2A ADRENERGIC RECEPTOR GENE VARIANT AND WEIGHT LOSS FOLLOWING SWITCHING OF ANTIPSYCHOTICS TO ARIPIPRAZOLE OR ZIPRASIDONE, INTERNATTONAL CONFERENCE ON MEDTCAL AND HEALTH SCIENCES (ICMHS), Malaysian Society of Human Genetics, College of Pathologists, Academy of Medicine, Malaysia. (National) (22 May 2013 - 24 May 2013)
  13. The role of a biomedical scientist in fulfilling the promise of personalised medicine, 4th Malaysian Conference on Biomedical Sciences, Universiti Sains Malaysia (National) (10 May 2013 - 11 May 2013)
  14. Peripheral PDLIM5 expression in bipolar disorder and the effect of olanzapine administration, Symposium for Genetic and Genome Guided Personalized Medicine in Asia: Overview and Applications, Thailand Center of Excellence for Life Sciences (Public Organization) together with Faculty of Medicine, Ramathibodi Hospital, Faculty of Pharmacy Mahidol University, Department of Medical Sciences, Ministry of Public Health, and RIKEN, Genome Research Institute, Japan (International) (15 Jan 2013 - 16 Jan 2013)
  15. Peripheral PDLIM5 Expression in bipolar disorder and the effect of olanzapine administration, 10th Asia Pacific Conference on Human Genetics, Asia Pacific Society of Human Genetics (International) (05 Dec 2012 - 08 Dec 2012)
  16. Pharmacogenomics of Antiepileptics, International Neuroscience Symposium 2012, School of Medicine, University Malaysia Sabah (International) (23 Jul 2012 - 24 Jul 2012)
  17. A Journey through a clinical trial review (Interactive Session): Scope on "Informed Consent Form , Workshop on Clinical Trial Enabler Project, Clinical Research Centre, Ministry of Health (National) (10 May 2012 - 10 May 2012)
  18. Pharmacogenomics Studies in Multiethnic Malaysians, Symposium for Genetic and Genome Guided Personalized Medicine in Asia: Overview and Applications , Thailand Center of Excellence for Life Sciences (Public Organization) together with Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Department of Medical Sciences, Ministry of public Health,and RIKEN, Japan (International) (02 Feb 2012 - 03 Feb 2012)
  19. Association study of tryptophan hydroxylase 2 and serotonin transporter genes with major depressive disorder in Malaysian ethnic subgroups, 2nd Congress of the Asian College of Neuropsychopharmacology, Korean College of Neuropsychopharmacology and Neuroscience (International) (23 Sep 2011 - 24 Sep 2011)
  20. Pharmacogenomincs: Paving the Way to Personalised Medicine. , MGRC s 12th Eminent Speaker Series. 23rd June 2011. Zahurin Mohamed (Invited Speaker)., Malaysian Genome Research Centre (National) (23 Jun 2011 - 23 Jun 2011)
  21. The Pharmacogenomics Approach to Personalised Medicine., 1st Malaysia Conference on Rare Disorders and Medical Genetics. , Human Variome Project Consortium (National) (09 Jun 2011 - 10 Jun 2011)
  22. (1) Informed Consent Process (2) Exercise on Ethics, Good Clinical Practice Workshop. , Clinical Investigation Centre, UMMC.  (National) (07 Jun 2011 - 07 Jun 2011)
  23. Integration of Pharmacology Knowledge into Clinical Practice, 8th Asia Pacific Medical Education Conference, Medical Education Unit of the National University of Singapore (International) (28 Jan 2011 - 29 Jan 2011)
  24. Informed Consent, 12th Good Clinical Practice Workshop. UKM, Sekretariat Penyelidikan Perubatan dan Industri (Others) (14 Jun 2010 - 16 Jul 2010)
  25. Association of ABCB1 polymorphisms with risk of resistance to sodium valproate in Malaysian epilepsy patients , Australia-Malaysia Colloquium on Medical Science, Australian Embassy with MOSTI (National) (28 May 2010 - 29 May 2010)
  26. Overview of Research process, Research Methods Introductory Course 12-14 January. , Medical Education Research Development Unit (MERDU), Faculty of Medicine, University of Malaya (University) (12 Jan 2010 - 14 Jan 2010)
  27. Concept of Bioequivalence and the Malaysian Guidelines and Requirements for Bioequivalence Studies", National Workshop for Bioequivalence and Advanced Pharmacokinetics, , Universiti Kebangsaan Malaysia (National) (11 Nov 2008 - 12 Nov 2008)
  28. Concept of Bioequivalence and the Malaysian Guidelines and requirements for bioequivalence studies., National Bioequivalence and Advanced Pharmacokinetics Workshop 2008, Faculty of Pharmacy, Universiti Kebangsaan Malaysia (National) (29 Oct 2008 - 30 Oct 2008)
  29. Informed Consent, Good Clinical Practice Workshop, Clinical Research Centre, Kelantan. (National) (19 Jul 2008 - 21 Jul 2008)
  30. Informed Consent, Good Clinical Practice Workshop, Biotech Corp and Clinical Research Centre, Johor. (National) (17 Jul 2008 - 17 Jul 2008)
  31. Informed Consent, Good Clinical Practice Workshop. Sarawak. 26-28 May 2008., Clinical Research Centre, Sarawak. (National) (26 May 2008 - 28 May 2008)
  32. Informed Consent., Good Clinical Practice Workshop. Kota Kinabalu, Sabah. 22-24 April 2008., Clinical Research Centre, Sabah. (National) (22 Apr 2008 - 24 Apr 2008)
  33. Factors Influencing Absorption and Its Relationship with Bioequivalence Studies. Z.Mohamed. , Bioequivalence Study Workshop. 12th April 2002. Organised by the Ministry of Health., Ministry of Health, Malaysia (National) (12 Apr 2002 - 13 Apr 2002)
  34. Applications of Good Laboratory Practice in Biomedical Assay. Z Mohamed. , Good Laboratory Practice Seminar organised by the Ministry of Health. 2-3 Nov 2000, Ministry of Health, Malaysia. (National) (02 Nov 2000 - 03 Nov 2000)
ORAL PRESENTER
  1. Susceptibility and gene interaction study of the angiotensin II type I receptor gene with non-alcoholic fatty liver disease in a multi-ethnic population, 26th Scientific Meeting of the Malaysian Society of Pharmacology & Physiology, Malaysian Society of Pharmacology & Physiology (National) (18 May 2012 - 20 May 2012)
  2. Association of ABCB1 polymorphisms with response to sodium valproate in Malaysian epilepsy patients., Asian Pacific International Society for Study of Xenobiotics (APISSX) 2011. 22-25th April 2011. Z Mohamed, BS Haerian, KS Lim, CT Tan (Oral Presentation)., International Society for Study of Xenobiotics  (International) (22 Apr 2011 - 25 Apr 2011)
  3. The impact of TCF7L2 variants on antidiabetic treatment regime selection: a Malaysian perspective. Muhammad H Haron, R Pendek, Z Mohamed, VL Raj, NA Abdullah. , 16th World Congress on Basic and Clinical Pharmacology, International Union of Basic and Clinical Pharmacology (International) (17 Jul 2010 - 23 Jul 2010)
  4. Bioethics education for a globalised world: Educate, inform and empower. An analysis to examine the need for bioethics education, training and awareness. , 10th World Congress of Bioethics. Singapore July 2010. Oral Presentation, International Association of Bioethics (International) (08 Jul 2010 - 10 Jul 2010)
  5. Association of ABCB C1236T and C3435T polymorphisms with the risk of resistance to sodium valproate in Malaysian epilepsy patients. Z Mohamed, BS Haerian, EM Mohamed, KS Lim, HJ Tan, H Omar, S Mohammad, AA Raymond, CP Wong, SW Wong and CT Tan. Oral Presentation., 24th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology. , Malaysian Society of Pharmacology and Physiology (National) (05 Apr 2010)
  6. Association of TCF7L2 gene polymorphisms with Type 2 diabetes mellitus in Malaysia: A preliminary report.Muhammad Huzaimi Haron, Rokiah Pendek, Zahurin Mohamed, Nor Azizan Abdullah., 15th Congress of the Asean Federation of Endocrine Societies. 28-1 Dec 2009. Bangkok. , Journal of the Asean Federation of Endocrine Societies. (International) (28 Nov 2009 - 01 Dec 2009)
  7. SCN1A polymorphism in epilepsy patients receiving carbamazepine. BS Haerian1, EHM Mohamed, KS Lim, HJ Tan, VL Raj, CT Tan, AA Raymond, Z Mohamed., 16th International Congress of Neurology & Clinical Electrophysiology of Iran. 19-22 May 2009. Iranian Journal of Neurology. Vol 8 Supplement 1, Spring 2009, Iranian Journal of Neurology (International) (19 May 2009 - 22 May 2009)
  8. ABCB1/MDR1 C3435T polymorphism in epilepsy patients receiving carbamazepine. BS Haerian, Z Mohamed, CT Tan, AA Raymond, KS Lim, HJ Tan, EHM Mohamed and VL Raj., 8th Biennial Convention of the ASEAN Neurological Association (ASNA) & Neurosciences 2009, 20th Annual Scientific Meeting of the Malaysian Society of Neurosciences 2009. 1st 4th April 2009. Berjaya Times Square Hotel & Convention Centre, Kuala Lumpur (oral) (International) (01 Apr 2009 - 04 Apr 2009)
  9. The G-1438A polymorphism of the 5HT2A receptor gene and its association with schizophrenia in the Malaysian Population. Shamsul Mohd Zain, Tiong Chea Ping, Nor Zuraida Zainal, Zahurin Mohamed and Vijaya Letchimi Raj, 33rd Annual Conference of the Malaysian Society for Biochemistry and Molecular Biology, , Malaysian Society for Biochemistry and Molecular Biology (National) (27 Aug 2008 - 28 Aug 2008)
  10. T102C Polymorphism of Serotonin 2A (5HT2A) Receptor and Schizophrenia: A Preliminary Report.2008, Zahurin Bt Mohamed, 2nd National Colloquium & Workshop in Pharmacogenetics. Kota Bharu, Kelantan (National) (18 Aug 2008)
  11. VL Raj, N.Mahali, NZ Zainal and Z.Mohamed; T102C Polymorphism of Serotonin 2A (5HT2A) Receptor and Schizophrenia: A Preliminary Report, 2nd National Colloquium & Workshop in Pharmacogenetics. , Institute of Research in Molecular Medicine, Universiti Sains Malaysia (National) (26 Apr 2008 - 29 Apr 2008)
  12. C677T Polymorphism of Methylenetetrahydrofolate Reductase Gene and Increased Plasma Homocysteine Concentration In Ischaemic Stroke. EHM Mohamed, Tan KS, Z. Mohamed, JM Ali, CT Tan. Awarded Best Presenter , First North-South Workshops on Pharmacogenetics, Kuala Lumpur 12-13 December 2005. Awarded Best Presenter , USM (National) (12 Dec 2005 - 13 Dec 2005)
  13. Multidrug Resistance 1 MDR-1) Exon26 C3435T polymorphism is not associated with cyclosporine dose requirements in renal transplant recipients. HS Eng, SY Tan, CC Lang, AM Mustafa, WT Seet, Z Mohamed , International Conference on Health Sciences. 6th-8th May 2005. KL.,  (National) (06 May 2005 - 08 May 2005)
  14. Chinese has higher CYP3A5*3 allele frequency compared to the Malays and Indians in Malaysia. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed., 5th HUGO Pacific Meeting & 6th Asia-Pasific Conference on Human Genetics. 17-20 November 2004, Biopolis, Singapore.,  (International) (17 Nov 2004 - 20 Nov 2004)
  15. Application of Ligand-Receptor Binding Assays. Raja Elina Raja Aziddin, MR Mustafa, AM Mustafa, Z.Mohamed. , Malaysian Association of Clinical Biochemists 14th Annual Scientific Meeting 23- 24th July, 2004. , Malaysian Association of Clinical Biochemists (National) (23 Jul 2004 - 24 Jul 2004)
  16. Prevalence of Genetic Polymorphism for 5,10-Methylenetetrahydrofolate Reductase (MTHFR) in Multi Ethnic Malaysian Ischaemic Stroke Population. EHM Mohamed, Tan KS, Z.Mohamed, JM Ali, CT Tan. Awarded Best Scientific Paper, Malaysian Society of Neurosciences Annual Scientific Meeting 18th to 20th June 2004, Kucing, Sarawak, Malaysia. , Malaysian Society of Neurosciences (National) (18 Jun 2004 - 20 Jun 2004)
  17. PCR-RFLP: A tool for indirectly tailored drug therapy. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed, 7th Asian Conference on Analytical Science, Hong Kong, July, 2004.  (International) (07 Jun 2004 - 10 Jun 2004)
  18. R.E.R. Aziddin, MA Mohd, MR Mustafa and ZmOhamed "Antiinflammatory properties of the leaf extract of Mitragyna speciosa. ", 2003, Presented at the International Seminar on Natural Products: 19th Annual Seminar & Workshop of the Malaysian Natural Products Society, University Malaya, KL, Malaysia., , International Seminar on Natural Products: 19th Annual Seminar & Workshop of the Malaysian Natural Products Society, University Malaya, KL, Malaysia., , Malaysian Natural Products Society (International) (04 Aug 2003 - 05 Aug 2003)
  19. Effects of Selected Local Plant Extracts on Cytochrome P450 Enzymes. A.M. Mustafa, Z.Mohamed L.Z. Tan & Y.N. Razliyana , Malaysian Science and Technology Congress 2001 (MSTC 2001) 24-26 September 2001. Kota Kinabalu, Sabah., , UMS (National) (24 Sep 2001 - 26 Sep 2001)
  20. Pharmacokinetic profile of 50 mg of subcutaneous tramadol -a preliminary report. R.Vijayan, Z.Mohamed, Lucy Chan, Am Mustafa, G Ong & A.Delilkan., 9th World Congress on Pain in Vienna, Austria , 22 - 27 Aug 1999  (International) (22 Aug 1999 - 27 Aug 1999)
  21. Pharmacokinetic profile of 50 mg of subcutaneous tramadol a preliminary report. R.Vijayan, Z.Mohamed, Lucy Chan, Am Mustafa, G Ong & A.Delilkan. , 9th World Congress on Pain. Vienna, Austria. 22 - 27 Aug 1999 (International) (22 Aug 1999 - 27 Aug 1999)
  22. A pharmacokinetic and pharmacodynamic study of generic and brand name atenolol in hypertensive subjects. CC Lang, AM Mustafa, SL Chan, AM Choy, MR Mustafa & Z.Mohamed, IXth Southeast Asian Drug Metabolism Workshop. April 1998. Abstract P-25 (International) (09 Feb 1998 - 11 Feb 1998)
  23. Studies of CYP3A4 activity in humans. Z.Mohamed, AM Mustafa, SK Jamal, MR Mustafa, K Jeyalingam & CC Lang.Abstract OW-2, IXth Southeast Asian Drug Metabolism Workshop. April 1998. , Department of Pharmacology, University of Malaya (International) (02 Feb 1998 - 04 Feb 1998)
  24. High performance liquid chromatography of dextromethorphan and its main metabolite in human urine, 16th Congress of Pharmaceutical Sciences . 17-21 November 1997. Kuala Lumpur , Malaysian Pharmacy Society (National) (17 Nov 1997 - 21 Nov 1997)
  25. Nafcillin is a potent inducer of CYP3A4 activity in humans. (1997) . Z.Mohamed, A.M.Mustafa, S.K.Jamal, M.R.Mustafa, K.Jeyalingam, C.C.Lang., 22nd Annual Conference for Malaysian Society for Biochemistry and Molecular Biology. October 1997, Malaysian Society for Biochemistry and Molecular Biology (National) (13 Oct 1997 - 15 Oct 1997)
  26. Preliminary phenotyping of dextromethorphan oxidation in a Malaysian population. Y.H.Noraliza, C.C.Lang, A.Z.Mohd. Zain, Z.Mohamed., VIIIth Southeast Asian Drug Metabolism Workshop. JogJakarta 1996 (International) (15 Jul 1996 - 17 Jul 1996)
  27. The blood pressure-lowering effect of two saponins isolated from Dioscorea piscatorum. Zahurin Mohamed and A.M.Mustafa. , 7th South-East Asian - Western Pacific Meeting of Pharmacologists. Manila. P-C-12. Pg 105 (1995).  (International) (09 Jan 1995 - 11 Jan 1995)
  28. Caffeine metabolic pathways. Are they valid as in vivo and in vitro probe for human cytochrome P450 ? D.J.Birkett. W. Tassaneeyakul, M.E.Veronese, M.E. McManus, Z.Mohamed and J.O. miners., Proceedings of the 9th International Symposium on microsomes and drug oxidations. 1992, Sydney,  (International) (23 Nov 1992 - 25 Nov 1992)
POSTER PRESENTER
  1. Polymorphism of the resistin gene and their association with obesity and resistin levels in Malaysians , Human Genome Meeting 2014, Human Genome Organisation (International) (27 Apr 2014 - 30 Jul 2014)
  2. Non-alcoholic Fatty Liver Disease: A complex disease involving multiple gene interactions, 5th Pan Arab Human Genetics Conference , Golden Helix Institute of Biomedical Research, Dubai. (International) (17 Nov 2013 - 19 Nov 2013)
  3. Central adiposity and body composition as indicators of dyslipidaemia among adolescents in Kuala Lumpur: A case-control study, 26th Scientific Meeting of Malaysian Society of Pharmacology & Physiology, Malaysian Society of Pharmacology and Physiology (National) (18 May 2012 - 20 May 2012)
  4. Association of INSIG2 RS7566605 Polymorphism with obesity-related parameters in Malaysian Malays, Human Genome Meeting 2011, HUGO and UAE (International) (14 Mar 2011 - 17 Mar 2011)
  5. Angiotensin II Type I polymorphisms and the risk of non-alcoholic fatty liver disease (NAFLD), JSH Single Topic Conference on Non-Alcoholic Fatty Liver Disease. 17-20th November 2010. Tokyo, Japan, JSH Japan (International) (17 Nov 2010 - 20 Nov 2010)
  6. Tryptophan hydroxylase 2 (TPH2) gene is associated with major depressive disorder in the three main ethnic groups of the Malaysian population, 16th World Congress on Basic and Clinical Pharmacology, International Union of Basic and Clinical Pharmacology (International) (17 Jul 2010 - 23 Jul 2010)
  7. Association between neuregulin1 gene polymorphism with schizophrenia in three ethnic groups in the Malaysian population. Z Mohamed, CL Wan, LH Lian and NZ Zainal. Poster Presentation. , 24th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology.  (National) (05 Apr 2010)
  8. Association of ABCB1 and NR112 polymorphisms with response to carbamazepine in Malaysian epilepsy patients. BS Haerian, EHM Mohamed, KS Lim, HJ Tan, AA Raymond, CT Tan, CP Wong, SM Zain, SNM Roffeei and Z Mohamed. , American Society for Pharmacology and Experimental Therapeutics (ASPET). April 2010. Anaheim, California. Poster presentation, American Society for Pharmacology and Experimental Therapeutics (ASPET). (International) (05 Apr 2010)
  9. Association of FABP2 A54T polymorphism with sodium valproate responsiveness in Malaysian epilepsy patients. Mohamed EHM, Haerian BS, Mohammad Noor N, Lim KS, Tan HJ, Tan CT, Raymond AA, Wong CP and Mohamed Z. , 24th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology 2010. Poster Presentation., Malaysian Society of Pharmacology and Physiology (National) (05 Apr 2010)
  10. Association between single nucleotide polymorphisms of FAAH gene and GSTP1 gene with addiction to stimulants in the Malaysian population. MS Sim, VL Raj, A Hatim and Z Mohamed. , International Conference on Personalised Medicine and 5th Joint Conference on Pharmacogenetics. 19-20 September 2009. Hong Kong. (International) (19 Sep 2009 - 22 Sep 2009)
  11. G-2458A Lep gene polymorphism is associated with body mass index (BMI) in the Malaysian Population. YD Apalasamy, FM Moy, S Rampal, AM Bulgiba and Z Mohamed. , International Conference on Personalised Medicine and 5th Joint Conference on Pharmacogenetics. 19-20 September 2009. Hong Kong., University of Hong Kong (International) (19 Sep 2009 - 22 Sep 2009)
  12. Association between the serotonin transporter gene and major depressive disorder in three major ethnic groups in Malaysia. Nor Zainal, Zahurin M, Lian L Hoong, Vijaya L Raj, Elsa M Mohamed, Loke Ai Chin. , American Psychiatric Association Annual Meeting. May 16-21, 2009. San Francisco, USA (Poster), American Psychiatric Association (International) (16 May 2009 - 21 May 2009)
  13. Association of ABCB1 (MDR1) and SCN1A polymorphism with resistance to carbamazepine in Malaysian epileptic patients. Batoul Sadat Haerian, EHM Mohamed, Z.Mohamed, VL Raj, KS Lim and CT Tan. , Fifth Epilepsy Congress, Tehran 4-6 Nov 2008 (International) (04 Nov 2008 - 06 Nov 2008)
  14. Bioequivalence Study of Two Tablet Formulations of Salbutamol in Healthy Adult Subjects. Z Chik, RC Basu, D.Murugan, SM Khor, Z,Mohamed, R.Pendek and TC Lee, , 22nd Malaysian Society of Pharmacology & Physiology Scientific Meeting 2008, , Malaysian Society of Pharmacology & Physiology  (National) (27 Aug 2008 - 28 Aug 2008)
  15. Association analysis of the serotonin 5HT2C receptor and dopamine D3 receptor gene polymorphisms with schizophrenia in three ethnic groups. Zahurin Mohamed, Vijaya L Raj, Noor Fadzlin Mahalai, Siti Zaleha Suki, EHM Mohamed and Nor Zuraida Zainal , 33rd Annual Conference of the Malaysian Society for Biochemistry and Molecular Biology, , Malaysian Society for Biochemistry and Molecular Biology,  (National) (12 May 2008)
  16. Zahurin Bt Mohamed, Siti Zaleha Suki, Elsa Haniffah Mejia Mohamed, Vijaya L Raj and Nor Zuraida Zainal. Polymorphism of the Dopamine D3 Receptor Gene in Multi-Ethnic Patients with Schizophrenia. , International Conference on Pharmacogenomics, Korea, 2008 , Inje University College of Medicine (International) (10 Apr 2008 - 13 Apr 2008)
  17. Association Analysis of the serotonin 5HT2C receptor and dopamine D3 receptor gene polymorphisms with schizophrenia in three ethnic groupsZ.Mohamed, VL Raj, NF Mahali, SZ Suki, EHM Mohamed & NZ Zainal. pg. 3-72, 10th Southeast Asian Western Pacific Regional Meeting of Pharmacologists and 41st Annual Scientific Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists , Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (International) (03 Dec 2007 - 06 Dec 2007)
  18. Angiotensin-converting enzyme deletion (ACE D)polymorphism and ischaemic stroke in multi ethnic Malaysian population. EHM Mohamed, Tan KS, Z. Mohamed, JM Ali, CT Tan and Azman W, International Union of Pharmacology (IUPHAR), Beijing, China 2-7 July 2006  (International) (02 Jul 2006 - 07 Jul 2006)
  19. "Multidrug Resistance-1 (MDR-1) gene polymorphisms: Prevalence in different ethnic groups and correlation with cyclosporine concentration-to-dose ratio in renal transplant recipients. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z.Mohamed , 3rd World Congress of Nephrology, 26-30 June 2005, Singapore  (International) (26 Jun 2005 - 30 Jun 2005)
  20. The impact of cytochrome P450 3A5 genetic polymorphism on cyclosporine concentration-to-dose ratio in renal transplant recipients. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z.Mohamed, 3rd World Congress of Nephrology. 26-30 June 2005, Singapore  (International) (26 Jun 2005 - 30 Jun 2005)
  21. Allelic distribution of C3435T in different ethnic groups in Malaysia. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed., 5th HUGO Pacific Meeting & 6th Asia-Pasific Conference on Human Genetics. 17-20 November 2004, Biopolis, Singapore., , Biopolis (International) (17 Nov 2004 - 20 Nov 2004)
  22. Cytochrome P450 3A5 Polymorphisms in Malaysian Populations. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed, 36th Asia-Pacific Academic Consortium for Public Health (APACPH) Conference 2004, Brisbane, Australia. (Poster Presentation) , , Asia-Pacific Academic Consortium for Public Health (APACPH) (International) (20 Sep 2004 - 24 Sep 2004)
  23. The MDR Variant Allele Frequencies in the two major ethnic Populations in Malaysia. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed., 36th Asia-Pacific Academic Consortium for Public Health (APACPH) Conference 2004, Brisbane, Australia. (Poster Presentation),  (International) (20 Sep 2004 - 24 Sep 2004)
  24. HS Eng, SY Tan, CC Lang, ME Phipps, AM Mustafa, WT Seet and Z Mohamed. PCR-RFLP: A tool for indirectly tailored drug therapy. , The 7th Asian Conference on Analytical Science, Hong Kong, July, 2004. (Poster Presentation) (International) (20 Jul 2004 - 24 Jul 2004)
  25. Effects of selected bioactive compounds from grapefruit (citrus paradis) and pomelo (citrus grandis) on the cytochrome P450 3A4 system. , 5th FAOPS Congress. Federation of Asian and Oceanian Physiology Society, 23-26 September 2002. Kuala Lumpur., Malaysian Society of Pharmacology and Physiology (International) (23 Sep 2002 - 26 Sep 2002)
  26. Assessment of the Bioequivalence of Enalapril Pharmacokinetic or Pharmacodynamic Approach? Shiau-Leng Tan, Toong-Chow Lee and Z.Mohamed. , 5th FAOPS Congress. Federation of Asian and Oceanian Physiology Society, 23-26 September 2002. Kuala Lumpur., FAOPS and Malaysian Society of Pharmacology and Physiology (International) (23 Sep 2002 - 26 Sep 2002)
  27. CYP2C19 genotype and Phenotype in a Malaysian population using omeprazole as the probe drug. Z.Mohamed, YS Pang, TC Lee, AM Mustafa, CC Lang, XIVth World Congress of Pharmacology. 7th 12th July 2002. San Francisco, California, USA., International Union of Pharmacology (International) (07 Jul 2002 - 12 Jul 2002)
  28. Gas Chromatographic Mass Spectrometric Analysis of captopril and its Application to Pharmacokinetic Studies. Z.Chik, A.M. Mustafa, Z.Mohamed & T.C.Lee. ASIANALYSIS VI, The Sixth Asian Conference Conference on Analytical Science. Tokyo 2001. IPA-30, The Sixth Asian Conference Conference on Analytical Science. Tokyo 2001. IPA-30 (International) (06 Aug 2001)
  29. Inhibition of cytochrome P450 2D6 activity in rat liver microsomes by quercetin.HA Abouazra, CE Ong, AM Mustafa & Z.Mohamed. , 15th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology , Malaysian Society of Pharmacology and Physiology  (National) (07 May 2001 - 08 May 2001)
  30. Determination of enalapril and its active metabolite enalaprilat in plasma by Gas Chromatography Mass Spectrometry. Tan Shiau Leng, T.C.Lee, Z.Mohamed & A.M. Mustafa., ASIANALYSIS VI, The Sixth Asian Conference on Analytical Science. Tokyo 2001. IPA-29,  (International) (05 Feb 2001 - 09 Feb 2001)
  31. Gas Chromatographic Mass Spectrometric Analysis of captopril and its Application to Pharmacokinetic Studies, Z.Chik, A.M. Mustafa, Z.Mohamed & T.C.Lee. "Gas Chromatographic Mass Spectrometric Analysis of captopril and its Application to Pharmacokinetic Studies. ", 2001, ASIANALYSIS VI, The Sixth Asian Conference Conference on Analytical Science. Tokyo 2001. IPA-30,  (International) (05 Feb 2001 - 08 Feb 2001)
  32. Single oral omeprazole pharmacokinetics and CYP2C19 activity in Malaysian subjects. A.Doci, YS Pang TC Lee, Z.Mohamed, AM Mustafa & CC Lang., Joint Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and The British Pharmacological Society. 25-28 April 2000. Melbourne, Australia.,  (International) (25 Apr 2000 - 28 Apr 2000)
  33. The effects of fluoxetine on the in vitro CYP2D6-dependent metabolism of dextromethorphan in Sprague-Dawley rat. Z.Adam, CE Ong, A.M Mustafa & Z.Mohamed. , 14th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology . 7-9 Mei 1999, Malaysian Society of Pharmacology and Physiology  (National) (07 May 1999 - 09 May 1999)
  34. Occurrence of the CYP2D6 gene duplication and deletion, and the CYP2D*610A,10B Chinese allelle in an Asian population. JY Wong, S.Wise, Z.Mohamed, Noraliza Yusof & EJD Lee. , IXth Southeast Asian Drug Metabolism Workshop. April 1998. Abstract OW-7., University of Malaya (International) (10 Nov 1998 - 18 Dec 1998)
  35. Does gestational age affect gentamicin pharmacokinetic parameters in the newborn? Z.Mohamed. O.Farizaturradiah, S.M.Sim, C.T.Lim. , 16th Congress of Pharmaceutical Sciences . 17-21 November 1997. Kuala Lumpur., Malaysian Society of Pharmaceutical Sciences (International) (17 Nov 1997 - 21 Nov 1997)
  36. Major differences in bioavailability of two generic products of nifedipine when compared to the proprietary nifedipine. Z.Mohamed, A.M. Mustafa, S.K. Jamal, C.T.Chua, K.Jeyalingam, M.R.Mustafa. Abstract A6., , Research Colloquim of the University of Malaya , University of Malaya  (University) (04 Aug 1997 - 05 Aug 1997)
  37. Caffeine metabolism by rabbit liver microsomes. Z.Mohamed, J.O. Miners and D.J. Birkett. , Sixth South East Asian Western Pacific Regional Meeting of Pharmacologists. Hong Kong. P-204. (1991)., University of Hong Kong (International) (10 Jun 1991)
  38. Characterisation of caffeine metabolism in human liver microsomes. Z. Mohamed., 9th Scientific Meeting of the Malaysian Society of Pharmacology and Physiology. (1991) , Malaysian Society of Pharmacology and Physiology. (National) (03 Jun 1991 - 04 Jun 1991)
  39. Caffeine metabolism by rabbit liver microsomes. Z.Mohamed, J.O. Miners and D.J. Birkett.P-204., Sixth South East Asian Western Pacific Regional Meeting of Pharmacologists. Hong Kong. (1991)  (National) (12 May 1991 - 14 May 1991)
  40. An in vitro screening technique for the detection of photosensitising compounds. Z.Mohamed, Noraini Mahyuddin and Muhamad Zakaria, 8th National Seminar and UNESCO Regional Workshop on the Bioassay of Natural Products. (1991) (International) (06 May 1991 - 07 May 1991)
  41. Some aspects of the disposition and metabolism of 8-methoxypsoralen in experimental animals. Z.Mohamed, South East Drug Metabolism Workshop. Singapore. Abstract 18. , NUS (International) (14 Jun 1987 - 16 Jun 1987)
  42. Some studies on the metabolism of 8-methoxypsoralen in both the in vivo and in vitro systems. Z. Mohamed and I.H.Stevenson., First South East Asian Drug Metabolism Workshop, Singapore, NUS (International) (15 Jun 1986 - 17 Jun 1986)
  43. The effects of 8-methoxypsoralen on the drug metabolising enzymes. Z. Mohamed.C.12.4 (1985). , Fourth South-East Asian Western Pacific Regional Meeting of Pharmacologists. Penang. , Malaysian Society of Pharmacology and Physiology (National) (16 Jun 1985 - 18 Jun 1985)
  44. The identification of a major metabolite of 8-methoxypsoralen in rat bile and its photosensitising property. Z.Mohamed , Fourth South-East Asian Western Pacific Regional Meeting of Pharmacologists. Penang, Malaysian Society of Pharmacology and Physiology (National) (16 Jun 1985 - 18 Jun 1985)
  45. The in vitro metabolism of psoralens used in photochemotheraphy. N.C.IIes,Z.Mohamed, D.C.Old, B.E. Johnson & I.H.Stevenson. , British Journal of Pharmacology Scientific Meeting. 81 - 83. 443P. (1984) (International) (20 Nov 1984)
  46. Some aspects of the disposition and metabolism 8-methoxypsoralen in experimental animals. Z.Mohamed, J.D. Baty, S.F. Fan & I.H. Stevenson. , British Journal of Pharmacology Scientific Meeting. 80, 167P, (1983) (International) (07 Nov 1983)
PRESENTER
  1. Validated Assay for Assessing CYP2C19 and CYP3A4 activities simultaneously using rat liver microsome. GY Christina, Z Mohamed and Ruby Husain , International Conference on Health Sciences. 6th-8th May 2005. KL. (International) (06 May 2005 - 08 May 2005)
  2. Effects of some endocrine chemicals on male rats . Normadiah K, Massaoud AD, Mustafa AM, Ruby H and Mohamed Z., European Journal of Anatomy, Vol 6, Suppl 1 pp 45-46, July 2002 (International) (18 Jul 2002)
  3. Single oral omeprazole pharmacokinetics and CYP2C19 activity in Malaysian subjects. A.Doci, YS Pang TC Lee, Z.Mohamed, AM Mustafa & CC Lang. , Joint Meeting of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and The British Pharmacological Society. 25-28 April 2000. Melbourne, Australia. (International) (25 Apr 2000 - 28 Apr 2000)
  4. Preliminary phenotyping of dextromethorphan oxidation in a Malaysian population. Y.H.Noraliza, C.C.Lang, A.Z.Mohd. Zain, Z.Mohamed. , Eighth Southeast Asian Drug Metabolism Workshop. JogJakarta (1996)., University of Jogjakarta (International) (09 Sep 1996)
OTHERS
  1. Scenario for Development of a Draft of the Code of Conduct for Biosecurity, Workshop for the Development of a National Code of Conduct for Biosecurity, Science and Technology Research Institute for Defence (STRIDE, Ministry of Defence) (National) (03 Jun 2015 - 04 Jun 2015)
  2. Participant, Faculty of Medicine Research Week, Department of Pharmacology and Department of Pharmacy, Faculty of Medicine, University of Malaya (University) (11 May 2015 - 15 May 2015)
  3. Did not present. Invited participant (Discussant), Persidangan Meja Bulat Sehari " Umat Islam dan Neurosains: Antara Tuntutan dan Kewaspadaan", IKIM (National) (12 Jun 2014 - 12 Jun 2014)
  4. Convention for Biological Weapons and Toxins, Workshop on Law on Convention for Biological Weapons and Toxins, Science and Technology Research Institute for Defence (National) (19 Jul 2012 - 19 Jun 2012)

ACADEMIC/PROF. SERVICES

Evaluation
  1. (2017) PhD Thesis for IIUM, (External Examiner)
  2. (2017) External Examiner for the Professional Examination of the Medical Course at Lincoln University , (External Examiner)
  3. (2015) June 2015. Evaluation of the standard of the examination and examination scheme carried out by the Faculty of Dentistry, UKM. Observes the practicals and academic matters relating to the students. Studies the programmes that are being offered. , (External Examiner)
  4. (2015) PhD (USM): 2015. Munavar Miya Shaik; Thesis entitled "The Association of MTHFR 677C>T, ESR 325C>G, 594G>A and TNF-a-308G>A Gene Polymorphisms with Migraine , (External Examiner)
  5. (2014) Assessment of the Curriculum, the Examination, Standards, of this course for this newly set-up Faculty, (External Examiner)
  6. (2014) Member of Assessor for Audit and Accreditation of Clinical Masters Programme at UKM, (Auditor)
  7. (2014) Reviewer for sceintific journal called "Pharmaceutical Biology" for a manuscript entitled "Comparison of Inhibitory Potentials of Mitragynine, 7-Hydroxymitragynine,Buprenorphine and Ketamine on 4-Methylumbelliferone Glucuronidation by Human Liver". Sept 2014. Microsomes and Recombinant Human UGT Isoforms, (Reviewer)
  8. (2014) This evaluation involves the entire Pharmacy Course that is offered by the International Medical University for the entire session 2013/2014. I am required to look through examination papers and observation of the examination procedure, and also evaluation of the assessments that have been made by the IMU academic staff , (External Examiner)
  9. (2014) USM: Masters. Nanthini A/P Jayabalan "Cannabinoid (CB) 1 Receptors in the Cerebellum as molecular targets of Mitragyna Speciosa (ketum) addiction in mitragynine-sensitised albino Swiss Mice", (External Examiner)
  10. (2014) Reviewer for Journal of Pharmaceutical Biology. Entitled " Comparison of Inhibition Potentials of Mitragynine, 7-hydroxymitragynine and several commonly abused drugs ----", (Reviewer)
  11. (2014) Article in Human Genetics (Impact Factor = 4.8) TITLE: Deep targeted resequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PPARVB with the severity of nonalcoholic fatty liver disease AUTHORS: Kitamoto, Takuya; Kitamoto, Aya; Yoneda, Masato; Hyogo, Hideyuki; Ochi, Hidenori; Mizusawa, Seiho; Ueno, Takato; Nakao, Kazuwa; Sekine, Akihiro; Chayama, Kazuaki; Nakajima, Atsushi; Hotta, Kikuko, (Reviewer)
  12. (2013) Reviewer for article for Human Genetics (Impact Factor = 4.7.Deep targeted resequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PPARVB with the severity of nonalcoholic fatty liver disease., (Reviewer)
  13. (2013) Promotion to Professor for Taylor's University, (Reviewer)
  14. (2013) PhD (USM): Noordalilati Muhd Noor. Teratogenicity study of Hempedu Bumi (Andrographis paniculata) in rats., (External Examiner)
  15. (2013) BMedScience IMU: Lau Pui Shen. Functional characterisation of cytochrome P450 2C19 allelic variants CYP2C19*23 and CYP2C19*24., (External Examiner)
  16. (2013) Masters USM: Shafra Binti Zainal Abidin. Inhibitory Effects of Active Constituents and Extracts of Andropgraphis Paniculata on the Activities of UDP-Glucuronosyl Transferases (UGTs)., (External Examiner)
  17. (2013) BMedSci (IMU): Hsu Chia Jie. Identification of inhibitory effects on cytochrome P450 (CYP) 3A4 by edible bird nest (EBN) extracts in vitro, (External Examiner)
  18. (2013) Evaluation of the entire Medical Curriculum MBBS for the Second Year of UKM's Medical Programme, from the suitability and standard of the the examination, the conduct of the examination, research activities carried out within the department etc., (External Examiner)
  19. (2013) Masters thesis (USM): Seah Tiong Chai " Development of a cell-based green fluorescence protein assay for the screening of CYP3A4 inducers and inhibitors. , (External Examiner)
  20. (2013) Assessor for promotion to a professor position, (Assessor for Promotion to a Professor position)
  21. (2013) BMedSc (IMU): Lau Pui Shen. Functional characterisation of cytochrome P450 2C19 allelic variants CYP2C19*23 and CYP2C19*24., (External Examiner)
  22. (2012) PhD USM : Teratogenicity study olf Hempedu umi (Andrographis paniculata) in rats. July 2012. Noordalilati Muhd Noor. , (External Examiner)
  23. (2012) External Examiner for the IMU Medical Programme. Involves review of examination papers, examine the students, observe the examination processes and submit a written report., (External Examiner)
  24. (2012) BMedSc (IMU): Identification of inhibitory effects on cytochrome P450 (CYP) 3A4 by edible birds nest (EBN) extracts in vitro. Hsu Chia Jie (ME090226613). June 2012., (External Examiner)
  25. (2012) PhD Thesis (USM): Genotoxicity and Prenatal Development Toxicity Studies of Orthosiphon stamineus Aqueous Extract. Hussin Bin Muhammad. Jan 2012., (External Examiner)
  26. (2012) UKM Promotion to an Associate Professor position. Dr Kamisah Yusof. Feb 2012, (Assessor)
  27. (2011) Review Editor of Frontiers of Pharmacogenetics and Pharmacogenomics, (Editor)
  28. (2011) PhD Thesis USM: Genotoxicity and Teratogenicity Evaluation of Orthosiphon Stamineus Aqueous Extract. Hussin Bin Muhammad., (External Examiner)
  29. (2011) Manipal-Melaka MBBS Course for the Pharmacology component. 22-27 Feb 2011. , (External Examiner)
  30. (2011) Evaluation of the above course at the Kuliyyah of Dentistry, International Islamic University of Malaysia. 2-8 May 2011. , (External Examiner)
  31. (2011) External Member of Staff Selection Committee for Academic Appointments at Monash University. From Sept 2011., (Advisory Committee)
  32. (2011) Identification of human ABCC3 variants and functional analysis of the promoter variants: in vitro and human studies. Sasaki et al. Drug Metabolism and Pharmacokinetics. Reviewer of an article in an academic journal. , (Reviewer)
  33. (2011) Tier 1 Journal (Impact Factor 4.398) "Pharmacogenomics". Functional Variant from SCN1A: Influence on dose, serum levels and therapeutic outcome of monotherapy with first-line antiepileptic drugs. Reviewer of article in an academic journal. Nov 2011. , (Reviewer)
  34. (2011) External Assesor for selection of potential members of academic staff for Monash University , (Monash Univ Selection Committee for Academics)
  35. (2011) Masters Thesis (USM): Effects of Mitragyna speciosa extracts on drug metabolising enzymes. Juzaili Azizi. , (External Examiner)
  36. (2011) Tier 1 Journal with Impact Factor 4.398 "Pharmacogenomics". Association of genetic variants in six candidate genes with valproic acid therapy optimisation. Reviewer of article in academic journal. Feb 2011. , (Reviewer)
  37. (2011) PhD Thesis (Internal Examiner): Metamphetamine Dependence in Malaysia: Psychiatric Co-Morbidity and Suicidality, metamphetamine induced psychosis, genetic polymorphisms and treatment of metamphetamine-dependence using aripiprazole. Ahmad Hatim Sulaiman. , (Internal Examiner)
  38. (2011) No association of peptide tyrosine-tyrosine (PYY) gene R72T variant with obesity among the Kampar Health Clinic Cohort, Malaysia. Malaysian Journal of Nutrition. Reviewer of a full paper in a journal. , (Reviewer)
  39. (2010) Panel Penilai Pakar untuk Penilaian Pembiayaan Dana Kementeian Sains, Teknologi dan Inovasi, (Reviewer)
  40. (2010) Master Thesis: Effect of Phyllanthus niruri (Linn) on Phase i and II drug metabolism and its molecular mechanism elucidation in rat liver. Moath Kahtan Bashir. July 2010 (USM) , (External Examiner)
  41. (2010) PhD Thesis (Manipal University): Morphological changes in the testis and spermatozoa of mice treated with imatinib. Submitted to the Manipal University, India. June 2010. , (External Examiner)
  42. (2010) PhD Thesis (Manipal University): Effects of Tualang Honey on Reproductive System of Male Rats exposed to Cigarette Smoke. Mahaneem Binti Mohamed. USM. September 2010. , (External Examiner)
  43. (2010) New applications for Research University Grants for USM., (Assesor for Research Projects under RU Grants USM)
  44. (2010) Gene-wide tagging study revealed no association between ABCC2, ABCC5 and ABCG2 genetic polymorphism and multidrug resistance in epilepsy. Pharmacogenomics (ISI journal with Impact Factor = 4.398). Reviewer of an article in an academic journal. Reviewer of an article in an academic journal. August 2010. , (Reviewer)
  45. (2010) Ethical Perception of Modern Biotechnology among Muslims in Malaysia. Asia Pacific Journal of Molecular Biology and Technology. Reviewer of an article in an academic journal. Jan 2010. , (Reviewer)
  46. (2010) Pharmacokinetic consideration for prescribing in children. Medical & Health Review Journal. Reviewer of an article in an academic journal. 11 March 2010 , (Reviewer)
  47. (2009) PhD Thesis: The Predictive Value of Single Nucleotide Polymorphism of the Human Tumour Necrosis Factor-Alpha and Interleukin 10 in Human Gestational Diabetes Mellitus. Thesis by Shabnam Montazeri for Doctor of Philosophy (Community Health), conferred by the International Medical University. July 2009. , (External Examiner)
  48. (2009) PhD Thesis: Teratogenicity Study of Hempedu Bumi (Angrographis Paniculata) in Rats. External Examiner. USM. Thesis by Noordalilati Binti Muhd Noor. PhD. July 2009 , (External Examiner)
  49. (2009) 2nd Part of the Second Professional Examination, Pharmacology Subject, Kulliyah of Dentistry, International Islamic University Malaysia. June 2009, (External Examiner)
  50. (2009) BMedSc Thesis: Drug-Drug Interaction Between Sunitinib and Paracetamol in a Mouse Model: Biochemical and Histopathological Assessment . Adeline Lim Yi Ling. International Medical University , (External Examiner)
  51. (2009) Master in Medical Science Thesis: Multiresidue determination of quinolone and chloramphenicol in poultry muscles from Malaysian processing plants by high performance liquid chromatography tandem mass spectrometry. Marni Sapar. July 2009. Conferred by University of Malaya. , (Internal Examiner)
  52. (2009) BBiomedSc Thesis: Identification of BCR-ABL kinase domain mutations among patients with chronic myeloid leukemia. Liang Kai Ling. 2009. UM. , (Internal Examiner)
  53. (2009) Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies. Current Pharmacogenomics and Personalised Medicine. Reviewer of an article in an academic journal. Nov 2009. , (Reviewer)
  54. (2009) PhD Thesis: Effects of the Extracts and Active Constituents of Hempedu Bumi, Pegaga, and Misai Kucing on Cytochrome P450 Enzymes in Human Liver. Pan Yan. International Medical University. July 2009. , (External Examiner)
  55. (2009) PhD Thesis (Ineternational Medical University). Effects of the Extracts and Active Constituents of Hempedu Bumi, Pegaga, and Misai Kucing on Cytochrome P450 Enzymes in Human Liver. PhD. Pan Yan. July 2009. , (External Examiner)
  56. (2008) BMedSc Thesis: In vitro evaluation of interaction between Eurycomalia longifolia active constituents and human cytochrome P450. Ching Siau Ying. IMU. Nov 2008. , (External Examiner)
  57. (2008) PhD Thesis (USM). Drug interactions between imatinib and acetaminophen - Pharmacokinetic and histopathological studies in a mouse model. Mohamed Inthisham Mohamed Nassar. 2008. , (External Examiner)
  58. (2008) A pharmacokinetic interaction between propranolol and Eurycoma longifolia (Tongkat Ali). Shima'a Ahmed Benslman. MSc. 2008. USM., (External Examiner)
  59. (2007) Palm kernel oil blends as suppository bases in the delivery of aspirin. For Journal of the University of Malaya Medical Centre. Reviewer of an article in an academic journal., (Reviewer)
  60. (2007) BMedSc Thesis: The use of chimeragenesis to study structure-function properties of cytochrome P4502C isoenzymes in human liver. Jonathan Cheah Gin Guan. IMU. Nov 2007 , (External Examiner)
  61. (2007) PhD Thesis: Pharmacokinetic interaction study between ciprofloxacin and theophylline in healthy volunteers. Saeed Obeid Abdulla Alfadly. USM. 2007. , (External Examiner)
  62. (2007) BBiomedSc: Relationship between IL-5 levels and eosinophil count in Malaysian asthmatics. Affidah Binti Sabran. UM. 2007., (External Examiner)
  63. (2007) BBiomedSc: Screening of antioxidant activity of plant extracts: A comparison of different methods of assessment. Ahmad Bazli bin Abu Shuib. UM. 2007., (External Examiner)
  64. (2006) PhD Thesis: Drug metabolism and toxicity studies of Misai Kucing (Orthosiphon stamineus, Benth) in rats. Chin Jin Han. USM. 2006., (External Examiner)
  65. (2006) BMedSc Thesis: Catalytic activity and protein stability of cytochrome P450 2C8 (CYP2C8) allelic variants carrying mutation at amino acid Ile264. Rajinder Singh a/l Harjit Singh. IMU. 2006., (External Examiner)
  66. (2005) External Examiner MBBS UiTM Medical Professional 2 Examination 2005(Pharmacology) , (External Examiner)
  67. (2005) Masters Thesis: Kesan jangka panjang ekstrak etanol Andrographis paniculata (Burm. F) Nees ke atas tikus betina diabetik aruhan-streptozotocin. Ahmad Syahrin Bin Mohd Saifuddin. USM. MSc. 2005. , (External Examiner)
  68. (2005) PhD Thesis: Effect of pyramid environment on anti-wound healing properties of corticosteroids, nonsteroidal antiinflammatory drugs and anticancer agents in albino rats. Surekha R Kamath. Manipal University, India. April 2005., (External Examiner)
  69. (2005) BMedSc Thesis: Construction and characterisation of mutations at isoleucine 264 in cytochrome P450 (CYP) 2C* enzyme. Jonathan Ting Ee. IMU. , (External Examiner)
  70. (2004) PhD Thesis. Siti Amrah Bt Sulaiman. Kajian mengenai profail kontraseptif sediaan herba tradisional orang asli kaum temuan. PhD, Universiti Sains Malaysia. Disember 2004 , (External Examiner)
  71. (2004) External Examiner for Semester 3 Examination of the MBBS Course for International Medical University. December 2004., (External Examiner)
  72. (2004) MMedSc Thesis: Phytooestrogens (Genistein and Diadzein): Distribution in tempeh and their endocrine-modulating effects in mice. Jegathambigai R. 2004. , (Internal Examiner)
  73. (2004) BMedSc Thesis: Characterisation of in vitro modulatory effects of flavonoids on human cytochrome P450 (CYP) 2C8 isoenzyme. Pang Chia Yong. IMU. 2004., (External Examiner)
  74. (2004) PhD Thesis: Ethnic differences in drug responses and disposition. Wong Li Ping. UM. Jan 2004., (Internal Examiner)
  75. (2003) PhD Thesis: Kepentingan peranan gen enzim detoksifikasi dalam penyakit karsinoma hepatoselular: Kaitan polimorphisme gen, aras protein, aduk dan kerosakan oksidatif DNA serta kajian kultur sel HEPG2 tertransfeksi. Zalinah Ahmad. UKM. 2003., (External Examiner)
  76. (2002) PhD thesis UKM. Dr Azian Abdul Latif.Kesan Suplimentasi Vitamin E Kelapa Sawit (Palmvitee) Terhadap Respons Imun Dan Status Antioksidan: Kajian Pada Pembawa Hepatitis Dan Mencit Diperlaku Karsinogen. November 2002. , (External Examiner)
  77. (2001) PhD thesis : Abdul Rasyid (USM) for the thesis entitled Kajian Ultrasonografi Kesan Kurkumin Terhadap Pundi Hempedu Manusia. October 2001 , (External Examiner)
  78. (2001) MSc Thesis: The role of Cytochrome P-450 Monooxygenase in Braedybaenia similaris Tolerance Towards Metaldehyde. Sakinah Harith (UKM). August 2001 , (External Examiner)
  79. (2001) Masters Thesis: Kajian peranan sitokrom P-450 monoksigenase dalam kerintangan Bradybaena similaris terhadap metaldehida. Sakinah Binti Harith. MSc. UKM. 2001. , (External Examiner)
  80. (2001) MSc Thesis: Kajian Ketoksikan Akut dan Subkronik Pironaridina dan Artesunata. A'edah bte Abu Bakar (USM)January 2001., (External Examiner)
  81. (2000) External Examiner for the BDS Examination (for Pharmacology) at UKM. March 2000 and again in March 2002 , (External Examiner)
  82. (2000) PhD: Kajian ketoksikan akut dan subkronik pironaridina dan artesunat. A'edah Hj Abu Bakar. USM. 2000., (External Examiner)
  83. (1999) External Examiner for the MBBS Manipal-Melaka Programme (for Pharmacology) August 1999, for March 2000, for August 2002, Feb 2003, August 2008 and many more times --- latest being February 2011 , (External Examiner)
  84. (1998) Masters of Science (UKM). Kajian perencatan pertumbuhan tumor, aruhan apoptosis dan pengekspresan protein penindas tumor P53 oleh goniotalamin pada model tumor mamari tikus teraruh 7,12-dimetilbenz(A) antrasen. Shamsul bin Muhamad. August 1998., (External Examiner)
  85. (1998) Masters of Science (USM) Genetic Polymorphism of Debrisoquine Metabolism : A Preliminary Study in Malays with a View of Developing Clinical Applications. Ahmad Hussein. MSc. May 1998, (External Examiner)
  86. (1997) Masters of Biomedical Science (UKM). Thesis entitled The Study of Adenosine Deaminase Activity and of Adenosine, Inosine and Hypoxanthine in Cerobrospinal Fluid and Serum of Rabbits induced with Meningitis. Haslida bt Hussin. M.Sc. March 1997., (External Examiner)
  87. (1996) Masters Thesis: Pengkajian aktiviti adenosin deaminase serta adenosin, inosin dan hipoxantin di dalam cecair serebrospina dan serum arnab teraruh meningitis. Haslida Binti Husin. UKM. Masters in Biomedical Science. 1996. , (External Examiner)
  88. (1995) Masters of Science (USM). Thesis entitled Cardiovascular Studies in an Animal Model of Diabetes. Mahgub A.Abugama. M.Sc. January 1995. , (External Examiner)
Contribution to external organisation
  1. (2017) Member of the International Union for Basic and Clinical Pharmacology, Pharmacogenomics Section since March 2016 (Asian Region), the most prestigious organisation for pharmacologists in the world. (http://www.iuphar.org/index.php/sections-subcoms/genetics-genomics/governance ), International Union for Basic and Clinical Pharmacology, Pharmacogenomics Section, International
  2. (2017) Appointment to the National Advisory Committee for the Malaysian Society for Pharmacology and Physiology, Malaysian Society of Pharmacology and Physiology, National
  3. (2017) Pelantikan Sebagai Felo Penyelidik Bersatu, Pusat Kajian Kecemerlangan Melayu (PKKM), University
  4. (2017) Pharmacogenomics Working Group under the Global Genomics Medicine Collaboration (representing Malaysia), Global Genomics Medicine Collaboration, International
  5. (2017) Panel/Committee Member of the Malaysian Phase 1 Clinical Trial Guideline. Published Nov 2017, Clinical Research Malaysia and Ministry of Health, Malaysia
  6. (2015) Global Genomics Medicine Collaboration, Global Genomics Medicine Collaboration is based in University of Florida, International
  7. (2015) Panel member of the Development of the National Code of Conduct for Biosecurity, Science & Technology Research Institute for Defence (STRIDE), Ministry of Defence, Malaysia, National
  8. (2015) Chairman of the Conference , Golden Helix Symposium 2015, International
  9. (2015) Chairman of the Consensus Meeting for the Guidelines for the use of Human Biological Tissues for Research , Organised by Clinical Research Malaysia with the Ministry of Health, Malaysia
  10. (2015) Panel member for the development of the National Code of Conduct for Biosecurity, Science & Technology Research Institute for Defence (STRIDE), Ministry of Defence, Malaysia jointly with the US Department of defence
  11. (2013) Asian Network for Pharmacogenomics Research , Asian Network for Pharmacogenomics Research, International
  12. (2013) SouthEast Asian Consortium for Pharmacogenomics Research (SEAPHARM), Riken (Japan) and Thailand Centre of Excellence for Life Sciences, International
  13. (2013) Panel bagi Pemilihan Naib Canselor IPTA bagi Universiti Penyelidikan (Universiti Malaya), Jabatan Pengajian Tinggi (Bahagian Governan IPTA)
  14. (2013) Member of the National Committee for Clinical Research, chaired by the Director General of the Ministry of Health, Malaysia, Ministry of Health
  15. (2013) Member of the National Bioethics Council - continuation of the term (Ahli Majlis bagi Majlis Bioetika Negara - sambungan), Ministry of Science, Technology and Innovation
  16. (2013) Reviewer for Asia Pacific Journal of Public Health, Asia Pacific Journal of Public Health
  17. (2012) Panel Member for the Committee for Assessment of Exploratory Research Grant Scheme (ERGS)., Ministry of Higher Education
  18. (2012) Invited for a Presentation in the Capacity as Council Member of the National Bioethics Committee. The meeting was an Expert Meeting on "Ethics of the Use of Animals in Experimentation" organised by the Institute of Islamic Understanding 7 June 2012. Title of presentation "Current Ethical Issues and in the use of animals in Medical and Biomedical Research". , Institute of Islamic Understanding
  19. (2012) Panel Assessor for Committee on Pre-investigational New Drug Applications. Appointment under the Ministry of Health. , Ministry of Health, Malaysia
  20. (2011) Bioequivalence Studies Contract Research, Idaman Pharma Sdn Bhd, National
  21. (2011) UM-Aurigene Collaboration, Aurigene Discovery Technologies Limited, India , International
  22. (2011) Appointed a Council Member of the National Bioethics Committee. The Council was launched on 22 May 2012 by the Minister of MOSTI, YB Datuk Seri Panglima Dr Maximus Johnity Ongkili. I presented the Keynote Address at the Launch, entitled "Bioethics and Society".The Council plays an advisory role in all matters pertaining to bioethics in Malaysia., Appointment by the Ministry of Science, Technology and Innovation from Oct 2011.
  23. (2010) Contract Research (Bioequivalence Studies), Idaman Pharma Sdn Bhd, National
  24. (2010) Contract Research (Bioequivalence Studies), Dynapharm Sdn Bhd, National
  25. (2010) Research Collaboration, Chinese University of Hong Kong, International
  26. (2010) Member of the National Committee for the revision of the Malaysian Guidelines on Good Clinical Practice (GCP). This Guidelines is used for all GCP workshops that are carried out throughout the Clinical Research Centres under MOH, at the Universities and at Research Institutes. The numbers of GCP workshops throughout Malaysia are about 30-50 yearly. These are three-day workshops with an examination at the end. The same committee are involved in preparation of the examination module., Ministry of Health, Malaysia
  27. (2009) Contract Research (Bioequivalence Studies), SM Pharmaceuticals, National
  28. (2009) Contract Research (Bioequivalence Studies), Idaman Pharma Sdn Bhd, National
  29. (2009) Member of the National Pro-Tem Committee on National Bioethics Council (NBC). The NBC was only recently passed by Cabinet (September 2010). This committee recommends policies pertaining to issues on bioethics, an issue which would cut across numerous Ministries including Ministry of Health, Ministry of Science, Technology and Innovation, Ministry of Agriculture, Minstry of Education., Cabinet had recently approved the formation of the Council.
  30. (2009) Expert on Bioequivalence (BE) Studies and have been carrying out such studies for the manufacturers of generic drugs throughout Malaysia for the past 12 years since 1999. It is mandatory that BE studies be done for generic drugs before the drugs can be registered for sale in the country. There are only 3 or 4 such centres in the country. Companies that have used our services include Idaman Pharma Sdn Bhd, Pharmaniaga, CCM Pharma, Xepa Soul Pattinson., Various generic drug manufacturers
  31. (2008) Country Representative for the Asian Network of Pharmacogenomics Research in which research data on Pharmacogenomics research are shared, Asian Network of Pharmacogenomics Research, International
  32. (2006) Have been an invited speaker and facilitator for many Good Clinical Practice Workshops that have been organised throughout the country either by Clinical Research Centres under the Ministry of Health or others like HUKM. Have been a facilitator for GCP Workshops held in Kota Kinabalu (2008), Kucing (2008), Kuantan (2008), HUKM (2008, 2009, 2010) and UMMC (2006, 2007, 2008, 2009, 2010)., Clinical Research Centre, Ministry of Health.
  33. (2005) Contract Research (Bioequivalence Studies), PHARMANIAGA BERHAD, International
  34. (2004) Member of the National Committee on Good Laboratory Practice. This committee recommends policies pertaining to the mutual acceptance of data among international bodies in relation to GLP., Ministry of Health, Malaysia.
  35. (2002) Member of the National Bioequivalence Committee. This is a powerful committee which is chaired by the Director of tyhe National Pharmaceutical Control Bureau, decides on the national policies governing the quality of generic drugs including the regulations governing bioequivalence studies. Only generic drugs that have passed Bioequivalence Data can be marketed in Malaysia. This can make or break a generic drug manufacturer. This committee is involved in such decisions., Ministry of Health, Malaysia.
  36. (2001) Contract Research (Bioequivalence Studies), Upha, National
  37. (2000) Contract Research (Bioequivalence Studies), Duopharma, National
  38. (2000) Contract Research (Bioequivalence Studies), Luen Wah Medical Co., National
  39. (1999) Contract Research (Bioequivalence Studies), Ranbaxy, National
  40. (1999) Collaboration and Partnership in the establishment of the Shidmadzu-UM Centre for Xenobiotic Studies (SUCXeS), Fischer General Scientific (M) Sdn Bhd, International
  41. (1999) Collaboration and Partnership in the establishment of the Shidmadzu-UM Centre for Xenobiotic Studies (SUCXeS), United Nations University, International
  42. (1999) Contract Research (Bioequivalence Studies), PHARMANIAGA BHD, National
  43. (1999) Member of various committees under the Ministry of Health pertaining to Bioequivalence Studies, GLP, GCP and Traditional Medicine, Ministry of Health, National
  44. (1999) Collaboration and Partnership in the establishment of the Shidmadzu-UM Centre for Xenobiotic Studies (SUCXeS), Shimadzu (Asia ) Pacific Pte Ltd, International
  45. (1999) Contract Research (Bioequivalence Studies), Xepa-soul Pattinson, National
  46. (1999) Have been involved in Continuing Medical Education talks to medical doctors and other health providers throughout the country on the subject of Bioequivalence Studies. These talks are commisioned by Pharmaniaga. The venues for these talks include [1] Hospital Besar Kuantan (9 Oktober 1999)[2] Hospital Besar Kota Bharu (19 Nov 1999) [3] Hospital Besar Kuala Trengganu (29 June 2000) [4]USM (27 Sept 2000)[5] Hospital Kuala Krai (2001) [6] Klang GH 10th August 2004 [7] HUKM 9th September 2004 [8] Hospital Fatimah, Ipoh (23 March 2005) [9] Cancer Support Group, Putrajaya Hospital (26th March 2005) [10] Faculty of Medicine UiTM (18th April 2005) [11] Private Medical Practitioners Association of Selangor and KL (1st May 2005) [12] Damansara Specialist Hospital (11th May 2005) [13] UMMC Hari Jururawat Bioequivalence Studies: Ensuring Confidence in the Use of Generic Drugs (25th June 2005) [14] Hospital Kulim (14th July 2005) [15] Tawakal Specialist Hospital (17th August 2005) [16] Subang Jaya Medical Centre (19th August 2005) [17] Lourdes Medical Centre (27th September 2005) [18] Hospital Taiping (28th October 2005) , Pharmaniaga Sdn Bhd in conjunction with various hospitals
  47. (1999) Member of the National Committee for Clinical Research. This committee which is chaired by the Director General of Health, makes policies that have much impact on clinical research for the whole country and has been responsible for decisions such as the requirement for training for Good Clinical Practice (GCP) for doctors and research staff which is now strictly implemented., Ministry of Health, Malaysia.
  48. (1998) Contract Research (Bioequivalence Studies), Norse Crown, National
  49. (1998) Contract Research (Bioequivalence Studies), CCM PHARMA SDN. BHD, National
  50. (1997) Contract Research (Bioequivalence Studies), RAZA MANUFACTURING SDN BHD, National
  51. (1997) Contracted to carry out analysis of a medication, Veloo, Guna & Ramani Advocates and Solicirors, Singapore, Others
  52. (1995) Contract study to test toxicity of rubber gloves, Baxter Health Care SA, International

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2019) Molecular Studies of Non-Alcoholic Fatty Liver Disease, Tan Hwa Li
  2. (2019) Medicinal Plants and Pancreatic Lipas Activities, Atefehalsadat Seyedan
  3. (2019) Flavonoids and Colorectal Cancer, Sanaz Koosha
  4. (2019) Antidiabetic Properties of Khat, Abdul Samad Ahmed Mokbel Al-Salahi
  5. (2018) PDLIM knockout animals, Mohd Aizat Bin Mohd Zain
  6. (2018) Obesity and Khat, Mustafa Ahmed Al-Shagga
  7. (2018) Noni fruit and Drug Addiction, Megala A/P Narasingam
  8. (2018) Natural Product, Abdulmannan Hasan Saad
  9. (2018) Methadone and Sexual Dysfunction, Shahrzad Riahi
  10. (2017) Studies on Mitragyna, Kong Wai Mun
  11. (2017) Pharmacogenomics of Prostate Cancer, Prevathe Poniah
  12. (2017) Pharmacogenomics of Hepatitis B Infection, Behnaz Riazalhosseini
  13. (2017) Pharmacogenomics of Adverse Drug Reactions, Immaculate Langmia
  14. (2017) Natural Product, Elham Rouhollahi
  15. (2017) Molecular Studies of Amphetamine Dependence, Sim Maw Shin
  16. (2017) Molecular Approaches to Alzheimer's Diseases, Elham Amini (M0100121)
  17. (2017) Animal Model of Parkinson's Disease, Mojtaba Golpich (M0100121)
  18. (2016) Pharmacogenomics of Lymphoproliferative Disorder, Sujatha Suthandiram
  19. (2013) Genetics of Epilepsy, Yuka Nozaka
  20. (2012) Molecular Studies of Alzheimers Disease, Rana Ombakshah
  21. (2012) Animal Model of Alzheimer's Disease, Fatemah Hemmati (M0100121)
  22. (2011) Molecular Studies of Childhood Obesity, Anahita Hamidi
  23. (2010) Phytochemical screening and pharmacological studies of Mitragyna Species, Raja Elina Raja Aziddin
  24. (2010) Pharmacogenomics of Obesity, Yamuna Devi A/P Apalasamy
  25. (2010) Pharmacogenomics of Epilepsy, Batoul Sadat Haerian
  26. (2009) Pharmacogenomics of Non-Alcoholic Fatty Liver Disease, Shamsul Mohd Zain
Master
  1. (2014) Blood Cancers, Md Mirazul Islam
  2. (2013) Pharmacogenomics of Bipolar Disorder, Mohd Aizat Bin Mohd Zain
  3. (2011) The Use of Methadone Replacement Therapy for Heroin Addiction, Diong Shiau Hui
  4. (2011) Study of Olanzapine-Induced Obesity, Ng Mei Fong
  5. (2011) Pharmacogenomics of Epilepsy, Hidayati Binti Mohd Sha'ari
  6. (2011) Association between candidate genes and sexual dysfunction in patients with major depressive disorder, Nur Elia Binti Mohd Nazree
  7. (2009) Population Pharmacokinetics and Pharmacogenomics, Soobitha A/P Subenthiran
  8. (2009) Pharmacogenomics of Pre-Term Birth, Siti Zaleha Suki
  9. (2009) Pharmacogenomics of Endometrial Cancer, Afiqah Alyaa binti Md Fuzi
  10. (2009) Pharmacogenomics of Breast Cancer, Lee Ern Chi
  11. (2008) Pharmacokinetics of Testosterone, Didi Erwandi Bin Mohamad Haron
  12. (2008) Pharmacogenomics of Diabetes Insipidus, Dr Muhammad Huzaimi Bin Haron 02-06-2008
  13. (2008) Genetic polymorphism study of the methylenetetrahydrofolate reductase (MTHFR) and renin angiotensin system (RAS) in Malaysian ischaemic stroke population, Elsa Haniffah Mejia Mohamed
  14. (2007) Pharmacogenomics of Schizophrenia, Wan Ching Lee
  15. (2007) Pharmacogenomics of Major Depressive Disorder, Loke Ai Chin
  16. (2007) Pharmacogenomics of Drugs of Abuse, Gareth Sim Maw Shin
  17. (2006) Studies on antidiabetic and related effects of Momordica charantia, Azadirachta indica and Murraya koenigh extracts on normal and STZ-induced diabetic rats. Kaleswari Somasundaram. 2007., Kaleswari Somasundaram
  18. (2005) The effects of Citrus Grandis (pummelo) juice and its extracts on cytochrome P4502C19 and P450 3A4, Christina Gertrude Yap
  19. (2005) Effects of selected bioactive compounds from grapefruit (Citrus paradisi) and pomelo (Citrus grandis) on the cytochrome P450 3A4 system, Hasni Misbah
  20. (2004) Multidrug resistance-1 (MDR-1) and cytochrome P450 3A (CYP3A) gene polymorphisms: Allelle frequencies in healthy subjects and correlations with cyclosporine dose requirement and trough concentration-to-dose ratio in renal allograft recipients, Eng Hooi Sian
  21. (2003) Monitoring of phytooestrogens in human cord blood and plant-based food and studies of some of their pharmacological properties., Sathya Seelan s/o Natchimuthu
  22. (2000) Pharmacokinetics and bioequivalence syudies of enalapril and its correlation with angiotensin converting enzyme inhibition activity, Tan Shiau Leng
  23. (2000) Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects, Pang Yek Sze (University of Malaya (UM))
  24. (2000) Gas chromatography-mass spectrometric analysis of captopril and its application in pharmacokinetic studies in healthy subjects, Zamri bin Chik
  25. (1999) Pharmacokinetic parameters of gentamicin, amikacin, theophylline and sufentanil - A study in the Malysian population, Farizaturradiah Bt Osman
  26. (1994) Compounds of Homalium longifolium Benth, with special emphasis on photosensitising activities, Nor Ainy Bt Mahyudin
  27. (1988) Pharmacology of the Dioscorea species, Mustafa Ali Mohd
Under Graduate Students
  1. (2014) Industrial Training Placement Requisition for BSc (Biotechnology students) of Aimst University Faculty of Applied Sciences for 11 weeks. Jeremy Chew Zi Sheng and Lai Ying.
  2. (2013) Four-months Industrial Training of Suthasini A/P Poniah from Aimst University. Title "Association of polymorphism with obesity parameters in humans"
  3. (2013) Four-months Industrial Training of student Ling Wei Shyang from Aimst University. Project title "Antiobesity effect of Green Tea Extracts"
  4. (2011) MDEB 3401. Project Title: ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISM (SNPs) IN ADIPOQ & FTO GENE WITH CHILDHOOD OBESITY. SANDEE TUN. Matric No. MEB 090702. 2011/12
  5. (2011) MDEB3401. Project title: Angiotensin II type 1 receptor (AGTR1) GENE polymorphism PREDICTS RISK OF FIBROSIS IN nonalcoholic fatty liver disease. Ngoh Teck Keong. MEB090021. 2011/12
  6. (2011) Attachment from University of Naresuan, Thailand, for 3 months. Thanet Sornda and Narong Jaturas (Bachelor of Medical Science)
  7. (2011) ASSOCIATION OF PNPLA3 RS738409 SINGLE NUCLEOTIDE POLYMORPHISM WITH DEVELOPMENT AND PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD). Tan Hwa Li. Attachment from USM.
  8. (2010) Association study of the -866 G/A polymorphism of uncoupling protein 2 (UCP2) with certain obesity-related parameters in Malaysian Malay subjects. Amir Hakim Bin Mohd Yusof. B Biomedical Science. 2010/11
  9. (2010) Association of SOD2 gene polymorphisms with metamphetamine dependence and psychosis in Malaysian population. Ahmad Nur Fayyadh Bin Ahmad Jaafar. MEB070003. B Biomedical Science. 2010/11
  10. (2008) Relationship between T102C polymorphism of the 5HT2A receptor gene and occurrence of psychosis in patients with schizophrenia. Mohd Aizat Bin Mohd Zain. B Biomedical Science. 2008/09.
  11. (2008) Polymorphism of the T102C serotonin 2A receptor gene in multi-ethnic patients with major depressive disorder and its association with suicidal behaviour. Mohd Izwan Bin Zainol. B Biomedical Science. 2008/09.
  12. (2008) Association of G-1438A polymorphism of 5HT 2A receptor with schizophrenia and with response to risperidone treatment in Malaysian patients. Shamsul Bin Mohd Zain. B Biomedical Science. 2008.2009.
  13. (2007) The polymorphism of dopamine D3 receptor in multiethnic patients with schizophrenia. Siti Zaleha Suki. B Biomedical Science. 2007/08.
  14. (2007) Polymorphism of serotonin 5-HT 2C receptor in multiethnic patients with schizophrenia. Noor Fadzlin Bte Mahali. 2007/08.

TEACHING

Master
  1. (2010) Masters in Clinical Dentistry
  2. (2010) Masters in Psychological Medicine
  3. (2009) Masters in Clinical Dentistry
  4. (2009) Masters in Psychological Medicine
  5. (2008) Masters in Clinical Dentistry
  6. (2008) Masters in Clinical Dentistry
  7. (2008) Masters in Psychological Medicine
  8. (2007) Masters in Psychological Medicine
  9. (2006) Masters in Clinical Dentistry
  10. (2006) Masters in Psychological Medicine
Bachelor
  1. (2011) DNED2101 - Farmakologi
  2. (2011) MDEB2101 - Principles of General Pharmacology and Toxicology
  3. (2010) MBBS (Medical) Course
  4. (2010) MBEB2105 - General Principles in Pharmacology and Toxicology
  5. (2010) MTEB2302 - Professional Ethics in Biomedical Science
  6. (2010) MWEF2103 - Central Nervous System & Therapy
  7. (2009) MBBS (Medical) Course
  8. (2009) DNED2101 - Farmakologi
  9. (2009) MBEB2105 - General Principles in Pharmacology and Toxicology
  10. (2009) MDEB2101 - Principles of General Pharmacology and Toxicology
  11. (2009) MDEB3401 - Advanced Medical Pharmacology
  12. (2009) MTEB2302 - Professional Ethics in Biomedical Science
  13. (2009) MWEF2103 - Central Nervous System & Therapy
  14. (2008) DNED2101 - Farmakologi
  15. (2008) MBBS - Medical Degree
  16. (2008) MBEB2105 - General Principles in Pharmacology and Toxicology
  17. (2008) MDEB2101 - Principles of General Pharmacology and Toxicology
  18. (2008) MDEB3401 - Advanced Medical Pharmacology
  19. (2008) MTEB3302 - Professional Ethics
  20. (2008) MTEB3302 - Analytical Techniques in Clinical Toxicology and Xenobiotics
  21. (2008) MWEF2103 - Central Nervous System & Therapy
  22. (2007) DNED2101 - Basic Pharmacology to The Dental Students
  23. (2007) MBBS - Basic Pharmacology to Medical Students
  24. (2007) MBEB2105 - General Principles in Pharmacology and Toxicology
  25. (2007) MDEB2101 - Farmakologi
  26. (2007) MTEB3302 - Professional Ethics in Biomedical Research
  27. (2007) MWEF2103 - Central Nervous System & Therapy
  28. (2006) DNED2101 - Basic Pharmacology to The Dental Students
  29. (2006) MBBS - Basic Pharmacology to Medical Students
  30. (2006) MDEB2101 - General Principles in Pharmacology and Toxicology

SOCIAL RESPONSIBILITY ACTIVITIES

  • Board of Trustee for The Fund for The Renovation of Mosques in Kelantan Post-Flood (Ahli Lembaga Pemegang Amanah Tabung Ihsan Pemulihan Masjid Banjir Kelantan). Appointment by Senator Dato' Dr Asyraf Wajdi Dusuki, Chairman of The Fund. Patron is Yb Dato' Sri Mustapa Mohamed, Minister of Trade and Industry., (22 Jan 2015 - 22 Jan 2017)
  • Invited to a Talk Show On Slot On "Sains dan Islam" by Ikim On Friday 5th Sept 2014 At 12.30pm. The Talk Show Was On The Aggression On Gaza by The Israel Army and Hosted by The Deputy Director of Ikim Prof Datin Azizan Baharuddin., (05 Sep 2014 - 05 Sep 2014)
  • Member of The Council of Advisors of Persatuan Orang Kota Bharu (Pokb)for Special Funds for Kidney Patients At Hospital Raja Perempuan Zainab Ii, (04 Aug 2014 - 04 Aug 2017)
  • Member of Council for Steering Committee of The Persatuan Orang Kota Bharu, (04 Aug 2014 - 04 Aug 2017)
  • Advisor for Society for Muslim Medical Students (Persatuan Siswa-Siswi Perubatan Islam Universiti Malaya (Psipum) Since 1994 Till Present. The Last Agm Was Held At The Faculty of Medicine, UM, On Tuesday 8th July 2014, for Election of The Exco, (08 Jul 2014)
  • Council Member of The Villa Flora Condominium, Taman Tun Dr Ismail, (28 Jun 2014 - 01 Jul 2015)
  • Coordinator for The 5th Annual Ramadhan Project 2014 for Sponsorship Drive for Food Hampers to 110 Families At The Dbkl Flats, Kampung Kerinci, 200 Residents of Lembah Subang and 17 Girl Orphans At Baitul Izzah At Pinggir Taman Tun Dr Ismail., (02 Jun 2014 - 28 Jun 2014)
  • Ahli Persatuan Kemajuan Wanita Kelantan Di Kuala Lumpur dan Selangor (Puspa). Hadiri Majlis Pelancaran Buku "Biografi Tokoh Wanita Kelantan" Oleh Ybm Tengku Razaleigh Hamzah., (22 Mar 2014 - 22 Mar 2014)
  • Coordinated The Yearly Contribution of "Qurban in Cambodia", for Donation of Meat to The Needy Muslims in Cambodia, (01 Oct 2013 - 01 Nov 2013)
  • Organiser of a Talk by Miko Peled, Jewish American, Pro-Palestinian Activist, At The University of Malaya; On Behalf of Viva Palestinia Malaysia., (16 Jun 2013 - 16 Jun 2013)
  • Organiser of The Yearly Contribution to The Needy Families of The Kg Kerinci Dbkl Flats, (01 Jun 2013 - 07 Jul 2013)
  • Advisor to The Yearly Charity Ride Projects of The Universiti Teknologi Malaysia (UTM) Students. Students Ride from Kl to Johor to Collect Funds Along The Way for The Reconstruction of Gaza., (04 Oct 2010 - 25 Dec 2010)
  • Advisor for The Baktisiswa Sarawak 2010 Programme, Organised by Medsoc Medical Society, (01 Mar 2010)
  • Committee Member of Viva Palestina Malaysia (Formerly Known as Complete as Above). Chairman of The Awareness Subcommittee. Jan 2010 Till Now, (14 Jan 2010)
  • Advisor for Bengkel Upsr Bagi Science. Organised by Taman Tun Dr Ismail Residents Association, (15 Jun 2009)
  • Committee Member of Badan Kebajikan Taman Tun Dr Ismail (Bakti), a Community Group Involved in Charity and Social Activities, (02 Jun 2009)
  • Committee Member of Coalition of Ngos Against The Persecution of Palestinians (Complete). Deputy Chairman of The Awareness Subcommittee. Jan 2009-Jan 2010, (14 Jan 2009 - 14 Apr 2010)
  • Coordinator for The Monthly Contributions to Orphans At a Tahfiz in Kelantan, (08 Dec 2008 - 04 Jan 2010)
  • Coordinator for Yearly Contributions to The Needy Families of The Dbkl Apartments Prior to Ramadhan, (05 Mar 2007)
  • Committee Member and Member of Kanwork (Cancer Network), a Breast Cancer Support Group, (17 Jan 2006)
  • Honorary Secretary of The Health Awareness Network Initiatives, Old Girls Association of The Tunku Kurshiah College, March 2005 - 2007, (01 Mar 2005)
  • Member of The Organising Committee for The Yearly Regional Conference On Medical Management from The Islamic Perspective. 2000-2008, (18 Sep 2000 - 08 Sep 2008)
  • Member of The University of Malaya Medical Centre (Ummc) Academic Committee for The Welfare of Patients, (03 Jan 2000)
  • Member of The Masjid At-Taqwa and Been a Member of Various Subcommittees and Involved in Many Activities Organised by The Mosques Such as Presenting Talks On Medications., (17 Dec 1991)
  • Member of The Residents Association (Ra) of Taman Tun Dr Ismail and I Have Been Involved in Many Community Projects Organised by Ra Such as Their Family Day., (04 Dec 1990)